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Introduction
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The most common serious adverse life 
event is the experience of the death of a 
significant person. Grief is the most usual 
reaction to such a loss, and is considered 
a normal and natural, albeit difficult, 
transition (1).
Grief as a topic of study emerged in 20th 
century. Freud (1917), in his paper on 
mourning and melancholia attempted 
to differentiate the normal process of 
mourning from melancholia. Despite 
their similarities, Freud states, there 
are some fundamental differences: 
mourning is recognized as a healthy and 
normal process that is necessary for the 
recovery of the loss and would not be 
seen as pathology nor a need for medical 
intervention. However, melancholia is 
pathological condition, and a dangerous 
illness due to its poor prognosis and the 
common suicidal tendency (2). 
Though loss is an event that most people 
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will encounter multiple times in their 
lives, it also can be a severely stressing 
experience. Although grief usually 
resolves within a delimited period, it 
may still have negative consequences for 
the health of a person: the exacerbation 
of preexisting levels of depression (3), 
increased risk of suicide (4), anxiety 
disorders (5), and decline in cognitive 
functioning (6-9), physical health 
problems, and higher rates of disability, 
use of medication and hospitalization 
(10) have all been associated with grief.
Moreover, about 9-20% of the persons 
cannot deal with the loss and show 
symptoms of complicated and unresolved 
grief, termed prolonged grief disorder 
(PGD) (11). The prevalence varies 
with age, social, cultural and clinical 
background (12, 13). We can remember 
the famous queen of Castile, named 
Joanna the Mad, who could not cope 
with the death of her husband Philip the 
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Handsome, and during 8 months, she 
remained with her husband’s coffin in a 
funeral procession that awoke awe and 
fear in the population.
PGD includes a set of symptoms of 
separation distress, such as yearning for the 
deceased or intense feelings of loneliness; 
and traumatic distress, such as feelings 
of disbelief or that life is empty, being 
emotionally numb or troubled accepting 
the death, or bitterness. The symptoms are 
prominent, remain elevated at 6 months 
and beyond after the loss to the point of 
functional impairment, and are often 
resistant to antidepressant treatment (14, 
15). PGD strongly affects the wellbeing 
of the person and has a great impact on 
the quality of life (16, 17). PGD has been 
associated with sleep disturbances (18), 
depression and a higher risk of suicide 
(19), and poor health (20). The impact 
of PGD on the cognitive functioning of 
adults and elderly persons is less known.
This PhD thesis is divided into 8 chapters: 
Chapter 2 explores PGD, cognition and 
brain volumes. Chapter 3 focuses on PGD 
and cognitive decline. Chapter 4 explores 
PGD and sleep quality. Chapter 5 focuses 
on PGD and cortisol levels. Chapter 6 
presents the research on the relation of 
silent brain infarcts with depression in 
the elderly. Chapter 7 presents markers of 
cerebral small vessel disease with severity 
of depression in the general population. 
Finally, in chapter 8, I discuss the main 
findings of this thesis.
Cognition and Prolonged grief 
disorder
From the earliest clinical descriptions 
of grief, researchers have noted that 
individuals with PGD have greater 
neurocognitive deficits compared to 
persons with normal grief and persons 
without grief (21). Several studies 
investigated the relation of (acute) grief 
with cognitive impairment, showing 
memory decline (immediate and delayed 
recall) in participants with grief (22,23); 
and worse performance in tests of 
attention (24). 
Recently, a descriptive study examined 
global and domain-specific cognitive 
functioning in individuals with PGD 
using the Montreal test. They found that 
participants had lower total Montreal 
scores, and visuospatial and attention 
scores relative to control participants (25). 
Yet, the relation between PGD remains a 
gap in the literature.
Despite the absence of longitudinal 
studies of PGD and cognition, several 
explanations of the potential impact on 
cognitive decline have been put forward:
Persons, who lose a loved one, show 
13
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sensory-perceptual alterations that have 
been associated with hallucinations 
and delusions. These deficits are more 
common in persons with PGD than 
in those without PGD (25% and 2%, 
respectively) (26). Equally, the attention 
of persons with PGD is usually directed 
toward aspects of the environment 
associated with the deceased (27). These 
findings suggest that persons with PGD 
may exhibit attentional bias or impairment 
in their interpretation of information of 
their external environment (28). They also 
exhibit a grief-related avoidance behavior 
(29), which is positively associated with 
overall PGD symptom severity (30).
However, the temporal relation between 
PGD and cognition has not been 
determined; also, whether cognitive 
function in persons with PGD declines 
over the time has not been studied. We 
cannot rule out reverse causality; that is 
that cognitive problems precede the onset 
of grief and are related to its persistence. 
The underlying hypothesis for my thesis 
is that poor cognitive performance in 
persons with PGD relates with brain 
structural changes and the cognitive 
decline could be a symptom of the onset 
of a mild cognitive impairment.
The aim of this thesis was to examine 
the relationship of PGD with different 
domains of cognition, and with brain 
volumes assessed by MRI in the general 
population. We also compared the 
cognitive decline prospectively through 7 
years.
Sleep and Prolonged grief disorder
When a loved one dies, the majority 
of bereaved persons develops sleep 
problems, and this has been a frequent 
topic of study (31). Being widowed or 
without a partner has been associated 
with lower sleep quality (32). Few studies 
have study the prospective association 
between PGD and quality sleep, showing 
an overall poor sleep quality (33)
The aim of this chapter was to examine 
the relationship between the sleep 
qualities and sleep duration in persons 
with normal grief and PGD, and a non-
grieving reference group.
The hypothalamic-pituitary-adrenal 
axis and Prolonged grief disorder
Under conditions of stress, the 
hypothalamic-pituitary-adrenocortical 
(HPA) axis is stimulated and activates the 
secretion of cortisol into the bloodstream. 
An acute psychosocial stress like losing 
a loved one is typically accompanied 
by increased secretion of cortisol, as 
an adaptation to the stressor and then 
a return to normal levels; but it is the 
chronic dysregulation of cortisol that is 
14
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implicated in a host of psychological and 
physical health conditions (34).
Previous studies of grief and cortisol 
showed more dysregulation on cortisol 
patterns and an increased mortality risk 
of the bereaved person (35,36). These 
few previous studies showed conflicting 
and controversial results, in one study a 
flatter slope across the day was observed 
in persons with PGD, but in another 
study the occurrence of a flatter slope in 
persons with grief was independent of the 
symptoms of PGD (37,38). In this chapter, 
we aimed to examine the association of 
morning cortisol and summary cortisol 
measures, e.g. the slope and the morning 
rise, with grief and PGD. 
Silent brain infarcts and depression
Alexopoulus introduced the term 
of vascular depression in 1997, and 
presenting this hypothesis he postulated 
that cerebral small vessel diseases can 
cause or exacerbate depression in elderly 
people (39). Krishnan proposed the same 
concept focusing on vascular lesions such 
as white matter lesions (WMLs) using 
magneting resonance imaging (MRI) 
methods (40). In this chapter, we aimed to 
test the association of non-clinical cerebral 
small vessel disease with depression 
longitudinally in general population.
Study Setting
The analyses performed in this thesis were 
based on data from Rotterdam Study, a 
large population based prospective cohort 
among adults aged 55 or over living in the 
Ommoord district in the city of Rotterdam 
in The Netherlands (78 % of 10,215 
invitees) (21). In the Rotterdam Study, 
the measurement of PGD is through the 
Inventory of Complicated Grief (ICG), 
which was introduced in the fourth 
follow-up examination (2002-2004) of 
the original cohort and in the second 
follow-up examination of the additional 
cohort (2004-2005). All data for this study 
were collected during an interview at the 
participant’s home. (41).
15
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 Cognition, structural brain changes and complicated grief
Background. Several psychosocial risk 
factors for complicated grief have been 
described. However, the association 
of complicated grief with cognitive 
and biological risk factors is unclear. 
The present study examined whether 
complicated grief and normal grief 
are related to cognitive performance 
or structural brain volumes in a large 
population-based study.
Method. The present research comprised 
cross-sectional analyses embedded in the 
Rotterdam Study. The study included 
5501 non-demented persons. Participants 
were classified as experiencing no grief 
(n = 4731), normal grief (n = 615) or 
complicated grief (n = 155) as assessed 
with the Inventory of Complicated 
Grief. All persons underwent cognitive 
testing (Mini-Mental State Examination, 
Letter–Digit Substitution Test, Stroop 
Test, Word Fluency Task, word learning 
test – immediate and delayed recall), and 
magnetic resonance imaging to measure 
general brain parameters (white matter, 
gray matter), and white matter lesions. 
Total brain volume was defined as the sum 
of gray matter plus normal white matter 
and white matter lesion volume. Persons 
with depressive disorders were excluded 
and analyses were adjusted for depressive 
symptoms.
Results. Compared with no-grief 
participants, participants with complicated 
grief had lower scores for the Letter–Digit 
Substitution Test [Z-score −0.16 v. 0.04, 
95% confidence interval (CI) −0.36 to 
−0.04, p = 0.01] and Word Fluency Task 
(Z-score −0.15 v. 0.03, 95% CI −0.35 to 
−0.02, p = 0.02) and smaller total volumes 
of brain matter (933.53 ml v. 952.42 ml, 
95% CI −37.6 to −0.10, p = 0.04).
Conclusions. Participants with 
complicated grief performed poorly in 
cognitive tests and had a smaller total 
brain volume. Although the effect sizes 
were small, these findings suggest that 
there may be a neurological correlate of 
complicated grief, but not of normal grief, 
in the general population.
Key words: Brain lesions, cognitive 
performance, cognitive tests, complicated 
grief, normal grief, structural brain 
volumes.
Abstract
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The human reaction to bereavement is 
characterized by a variety of feelings, 
thoughts and behaviors, of which grief 
is often regarded as the most common 
reaction (Rozenzweig et al. 1997). One 
possible consequence of bereavement 
is an unresolved and prolonged grief, 
termed complicated grief. Complicated 
grief includes a set of symptoms such 
as persistent intense yearning, and 
longing for and disruptive preoccupation 
with thoughts of the deceased. These 
symptoms are prominent, elevated at 6 
months and beyond after the loss, and are 
often resistant to antidepressant treatment 
(Pasternak et al. 1991; Horowitz et al. 
1997).
Complicated grief has been referred to 
as ‘traumatic grief ’, ‘complicated grief 
disorder’ and as ‘prolonged grief ’ (Shear 
et al. 2011) and is distinctly different from 
depression ‘accounted for by bereavement’, 
as mentioned in the Diagnostic and 
Statistical Manual of Mental Disorders, 
fourth edition (DSM-IV). Recently, 
complicated grief has been included in 
the DSM-5 under the name ‘persistent 
complex bereavement disorder’ (Boelen 
& Prigerson, 2012).
Of the population experiencing 
bereavement, complicated grief affects 
between 9% and 20% (Newson et al. 
2011), with variations based upon social, 
cultural and clinical background as well 
as age. Complicated grief strongly affects 
the well-being of the bereaved (Lannen 
et al. 2008) and it is associated with sleep 
disturbances (Hardison et al. 2005), 
depression and a higher risk of suicide 
(Szanto et al. 1997), abuse of alcohol 
(Hardison et al. 2005) and poor health 
(Lannen et al. 2008).
In addition, psychosocial risk factors 
have been described, such as a loss, 
unexpected death or suicide (Ginzburg 
et al. 2002; Mitchell et al. 2004), lack of 
social support or inability to adapt to the 
resulting changes (Ott, 2003). However, 
the etiology of complicated grief is not 
well established.
Recently, a cross-sectional study of 211 
older adults reported that bereavement 
was associated with poorer memory 
performance, especially in men (Rosnick 
et al. 2010). 
Another study of 50 elderly people 
observed that bereaved persons 
performed worse in tests of attention, 
information processing speed, and verbal 
Introduction
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Study participants
The study utilizes data from the Rotterdam 
Study, a large population-based cohort 
designed to examine the occurrence of 
chronic diseases. The study has been 
described in detail elsewhere (Hofman 
et al. 2011) and was approved by the 
medical ethical committee of the Erasmus 
Medical Center. Participants gave written 
informed consent.
From July 2004 to September 2009, 6321 
persons were interviewed at home; this 
interview included the Inventory of 
Complicated Grief (ICG). Individuals with 
Mini-Mental State Examination (MMSE) 
score <23 (n = 346), major depression (n = 
112), and with an ICG score >22 but with 
less than 6 months since the loss of a loved 
one (n = 29), missing data on the MMSE 
(n = 163) or on the question ‘Are you 
currently experiencing grief?’ (n = 170) 
were excluded. Therefore 5501 eligible 
persons aged over 45 years, with complete 
data on complicated grief symptoms and 
cognitive functioning were available.
From August 2005 onwards, participants 
from the Rotterdam Study were invited 
for brain MRI. Individuals with dementia, 
claustrophobia or MRI contraindications 
were excluded. of the 4566 persons that 
fluency (Ward et al. 2007) when compared 
with non-bereaved persons. Furthermore, 
whether such associations also exist for 
complicated grief remains to be studied.
In the elderly, accumulating pathology in 
the brain can lead to structural changes 
visible on magnetic resonance imaging 
(MRI). These structural changes include 
cortical atrophy and white matter lesions, 
which have been associated with cognitive 
decline (Vernooij et al. 2009). Such 
changes could increase the vulnerability 
to complicated grief. However, studies 
exploring complicated grief and structural 
brain changes have not been performed. 
The aim of the current study was to 
examine the relationship of complicated 
grief with different domains of cognition 
and with brain volumes assessed by MRI 
in the general population. We tested two 
hypotheses. First, we postulated that 
persons with complicated grief symptoms 
perform worse in cognitive tests than 
those without grief or with normal grief. 
Second, we postulated that persons with 
symptoms of complicated grief have less 
brain volume than persons without grief 
or with normal grief.
Method
22
Chapter 2
were approached for imaging, 3759 
participated (84%). After the same 
exclusion criteria as above were applied, 
3607 persons with data on complicated 
grief for the structural MRI study were 
available.
Assessment of complicated grief
All participants were asked if they were 
currently grieving. If the answer was 
positive we asked formal follow-up 
questions ‘When did this person die?’, and 
‘Who was this person?’ Participants who 
were mourning over someone with severe 
disease or a pet were not eligible for follow-
up questions and classified as controls. 
The participants who answered the first 
question affirmatively were assessed for 
complicated grief with the Dutch version 
of the ICG (Prigerson et al. 1995). The 
ICG is considered the ‘gold standard’ 
for measurement of complicated grief in 
older adults because it has high internal 
consistency, and good convergent and 
criterion validity. A total of 17 questions 
were asked and responses were provided 
on a five-point scale to reflect an increase 
in severity (never, seldom, some-times, 
often, always) (Newson et al. 2011). One 
item from the original English inventory, 
‘I feel bitter over this person’s death’, was 
removed as a pilot study revealed that this 
sentiment had a very similar meaning 
within the Dutch language as the included 
item: ‘I feel anger over this person’s death’. 
Two further items (relating to seeing and 
hearing the deceased) were combined 
into one due to their similarity.
A summary score for the ICG was 
calculated by totaling each individual 
item score (responses from 0 = never to 
4 = always) across the 17 items providing 
a potential score range of 0 to 68. 
Participants with a score of less than 22 
were considered as participants with grief 
symptoms. Participants with a score of 22 
or greater and with symptoms reported 
for at least 6 months were considered 
to have complicated grief. This cut-off 
was based on the cut-off in the original 
version of the ICG (original cut-off of 25 
from 19 items).
We classified participants into three 
groups: no grief (control group); persons 
with ‘normal’ grief (experiencing non-
complicated grief as shown by an ICG 
score < 22); and those with complicated 
grief (ICG score >=22). The non-grieving 
control group included persons who had 
experienced bereavement in the past but 
were not grieving at the time of interview. 
Likewise, persons grieving for a pet or 
a loved one with a severe disease were 
included in the control group.
We also performed additional analyses, 
using a cut-off of 30, to define participants 
with complicated grief (Shear et al. 2005; 
23
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Zuckoff et al. 2006). This resulted in 703 
persons with ‘normal’ grief (experiencing 
non-complicated grief as shown by an 
ICG score <30) and 67 persons with 
complicated grief (ICG score >=30). An 
additional short assessment instrument 
with 13 items (including two severity 
questions) has been introduced to 
establish prolonged grief disorder. Seven 
of the eleven items correspond to items in 
the ICG. The mean score on these items 
for persons with complicated grief in our 
study was 14.13 v. 5.38 for persons with 
normal grief (p <=0.001).
Assessment of cognitive functions
All participants underwent the MMSE, the 
Stroop Test, the Letter–Digit Substitution 
Test (LDST), the Word Fluency Task, and 
a 15-word verbal learning test.
The MMSE is a widely used test for 
screening dementia and provides a reliable 
measure of global cognitive functions.
The LDST, a modified version of the 
Symbol–Digit Modalities Test, was used 
to measure processing speed. Substitution 
tests are essentially speed dependent 
tasks that require the subject to match 
particular signs symbols, digits or letters 
to other signs within a specified time 
period. Participants make as many letter 
digit combinations as possible within 60 
seconds, following an example that shows 
the correct combinations. 
The LDST has the advantage of using 
letters and digits, signs that are well known 
to those taking the test. Substitution tasks 
involve visual scanning, mental flexibility, 
sustained attention, psychomotor speed, 
and speed of information processing (van 
Hoof & Lezak, 1995; Natu & Agarwal, 
2002; Vander et al. 2006).
The Stroop Test consists of three standard 
trials. Trials 1 and 2 measure attention 
and concentration. In trial 1, the cards 
show color names printed in black and 
participants are asked to name the printed 
word. In trial 2, the cards show colored 
blocks and participants are asked to name 
the printed color. Trial 3 is an interference 
trial considered an effective measure of an 
executive function. The cards show color 
names printed in a different color from 
the color name and participants are asked 
to name the color of the ink. The outcome 
variable is the time needed to finish trial 3 
(Reeve & Schnadler, 2001).
The Word Fluency Task was used to 
test verbal fluency. Participants are 
asked to name as many animals as 
possible within 60 s. The 15-word verbal 
learning test tests memory functions 
with immediate recall and delayed recall 
components. Participants were given a list 
of 15 unrelated words repeated over five 
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different trials and were asked to repeat. 
Another list of 15 unrelated words was 
given and the client was asked again to 
repeat the original list of 15 words and 
again after 30 min. For each participant, 
we calculated Z-scores for each test 
separately except for MMSE.
We constructed a compound score for 
global cognitive function with the average 
of all individual tests except the MMSE 
(Prins et al. 2005).
Assessment of general cerebral 
parameters and white matter lesions
Brain MRI was performed on a 1.5 Tesla 
scanner (USA) with an eight-channel head 
coil and included T1-weighted, proton-
density-weighted and fluid-attenuated 
inversion recovery sequences (Ikram 
et al. 2011). Post-processing steps have 
been described elsewhere and include a 
conventional k-nearest-neighbor brain 
tissue classifier extended with white 
matter lesion segmentation (de Boer et al. 
2009), obtaining quantitative measures of 
white matter volume, gray matter volume 
and white matter lesion volume. Total 
brain volume was defined as the sum of 
gray matter plus normal white matter and 
white matter lesions.
Assessment of covariates
Potential confounders were selected 
based on previous publications and 
included determinants of grief or brain 
atrophy (Ikram et al. 2008; Rosnick et al. 
2010). Information was collected in home 
interviews and physical examination. The 
following variables were tested as possible 
confounders: age (continuously per year), 
sex, level of education (low, medium, 
high), systolic blood pressure (mmHg), 
diabetes mellitus, history of stroke, 
history of depression, history of anxiety, 
current depressive symptoms, and 
alcohol consumption. Diabetes mellitus 
was defined as a fasting serum glucose 
level of 57.0 mmol/l and/or the use of 
blood glucose-lowering drugs. Stroke 
was defined according to World Health 
Organization criteria as a syndrome 
of rapidly developing clinical signs of 
focal or global disturbance of cerebral 
function, with symptoms lasting 24 h 
or longer or leading to death. History of 
depression was defined by self-reported 
history of depression with treatment by 
a psychiatrist or psychologist or use of 
antidepressant medication as measured 
by pharmacy records as described 
previously (Luijendijk et al. 2008). History 
of anxiety was assessed by the Composite 
International Diagnostic Interview (Hek 
et al. 2011) according to DSM-IV criteria. 
Current depressive symptoms were 
assessed with a validated Dutch version 
of the Center for Epidemiologic Studies 
Depression scale (range 0–60) (Beekman 
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et al. 1997), with a score of 16 or above 
suggesting clinically relevant depressive 
symptoms. All participants with clinically 
relevant depressive symptoms were 
interviewed by one of two clinicians using 
the Present State Examination, a semi-
structured psychiatric interview (Wing et 
al. 1990). Participants with diagnosis of 
major depression, as classified according 
to the DSM-IV, were excluded.Alcohol 
consumption was classified as low if the 
participant drank zero to two glasses per 
day, moderate if he/she drank three to 
four glasses per day, and high if he/she 
drank five or more glasses per day.
Statistical analysis
Information on demographic 
characteristics was compared among the 
groups using a χ2 test for categorical data 
and an analysis of variance for continuous 
variables.
First, we investigated the association 
of complicated grief with measures of 
cognitive performance. We tested the 
differences between participants with 
normal grief and controls. Next we 
compared participants with complicated 
grief with controls as well as with those 
participants with normal grief (the latter 
two groups each used as reference) with 
analyses of covariance (ANCOVA).
Second, we explored the association 
of complicated grief with total brain 
volume and subsequently with gray 
matter, and white matter separately. Also, 
we investigated white matter lesions. 
Again, we compared the three groups 
using ANCOVA. We mutually adjusted 
brain volume parameters and cognitive 
function when testing the association 
with complicated grief.
All analyses were adjusted for age and sex, 
level of education, systolic blood pressure, 
diabetes, and history of stroke, history of 
depression and anxiety, current depressive 
symptoms, and alcohol consumption.
The ICG is designed as a screening 
measure and not to assess severity of 
grief. However, we performed continuous 
analyses in persons grieving using the 
scores on the ICG to test whether there 
is a dose response relationship between 
the grief symptoms score and cognition 
function or MRI brain measures 
independently of the predefined cut-off.
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Of the 5501 eligible participants, 4731 
were classified as experiencing ‘no grief ’, 
615 as experiencing ‘normal grief ’, and 
155 as experiencing ‘complicated grief ’.
Table 1 presents the characteristics of the 
study population. The main causes for 
grief were death of a partner (complicated 
grief, 26%; normal grief, 20%) or parent 
(complicated grief, 23%; normal grief, 
29%). When compared with persons 
without grief or with normal grief, 
participants with complicated grief were 
more likely to be female, older, have 
current depressive symptoms and a lower 
MMSE, consume less alcohol and have a 
history of depression, stroke and diabetes.
Table 2 shows the cognitive test scores 
across the three groups. Participants 
with complicated grief had lower scores 
in the LDST [Z-score −0.16 v. 0.04, 95% 
confidence interval (CI) −0.36, −0.04, 
p = 0.01] and the Word Fluency Task 
(Z-score −0.15 v. 0.03, 95% CI −0.35 to 
−0.02, p = 0.02) compared with no-grief 
participants. Participants with normal 
grief had slightly higher MMSE scores 
(score 28.2 v. 28.0, 95% CI 0.04–0.33, p 
= 0.01) than no-grief participants. No 
other differences were found. When 
participants with complicated grief were 
compared with those with normal grief, 
we found that they had significantly lower 
MMSE scores (score 27.7 v. 28.2, 95% CI 
−0.7 to −0.13, p = 0.004). 
Also, participants with complicated grief 
had lower scores in the LDST (Z-score 
−0.16 v. 0.03, 95% CI −0.36 to −0.02, p = 
0.02) and the Word Fluency Task (Z-score 
−0.15 v. 0.03, 95% CI −0.36 to −0.003, p = 
0.04) than participants with normal grief. 
No differences in the Stroop Test or word 
learning test, immediate and delayed 
recall, were observed between these two 
groups.
Next we compared the brain tissue 
volumes and white matter lesions across 
the three groups (Table 3). Of the 3607 
study participants, 3148 were classified 
as experiencing ‘no grief ’, 373 as ‘normal 
grief ’ and 86 as ‘complicated grief ’. When 
compared with no-grief participants, 
complicated-grief participants were more 
likely to have smaller total brain volume 
(volume 933.5 ml v. 952.4 ml, 95% CI 
−37.67 to −0.10, p = 0.04). Indeed, all 
the brain volume comparisons between 
non-grieving persons and those with 
complicated grief were consistently 
negative, indicating a smaller volume 
associated with complicated grief. No 
differences in brain tissue volumes 
between participants with normal grief 
Results
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and those without grief were observed. 
When we entered both cognitive and 
brain tissue volume parameters in a 
single model, the association between 
complicated grief and smaller total 
brain volume disappeared; however, 
the association between lower cognitive 
functioning and complicated grief 
remained (data not shown). When we 
performed analyses using a cut-off of 30 
to define complicated grief, we found that 
participants with complicated grief had 
lower MMSE scores than non-grievers 
(score 27.4 v. 28, 95% CI −1.00 to −0.16, p 
= 0.007) and normal grievers (score 27.4 
v. 28.2, 95% CI −1.18 to −0.31, p = 0.001). 
As in the analyses using a less stringent 
cut-off, consistent differences in cognitive 
para-meters (LDST, Word Fluency Task) 
were found, suggesting that persons with 
complicated grief perform worse in these 
tasks independent of the case definition.
Using the cut-off of 30 on the ICG to 
define complicated grief, we found that 
participants with complicated grief had 
less gray matter (volume 512.78 ml v. 
533.60 ml, 95% CI −37.90 to −3.72, p 
= 0.017) and less white matter volume 
(volume 387.14 ml v. 414.74 ml, 95% 
CI −46.92 to −8.28, p = 0.005) than 
participants with no grief. The total brain 
volume of participants with complicated 
grief was smaller (volume 903.31 ml v. 
952.42 ml, 95% CI −80.50 to −17.71, p = 
0.002) than that of participants with no 
grief. The continuous analyses in persons 
with grief showed that higher scores on the 
ICG were associated with lower MMSE 
score (B=−0.02, 95% CI −0.03 to −0.01, p 
= 0.002) and smaller total brain volumes 
(B = −1.28, 95% CI −2.16 to −0.40, p = 
0.004).
Table 1. Baseline characteristics of the study population (n = 5501)
Characteristics
Mean age, years (S.D.)
Women, n (%)
Education, n (%)
Primary
Intermediate
High
Alcohol consumption, n (%)
Low (0 to 2 glasses per day)
Moderate (3 to 4 glasses per day)
High (5 or more glasses per day)
Lives alone, n (%)
Who died?, n (%)
Partner
Child
Parent
Brother/sister
Others
Mean MMSE scorec (S.D.)
Depressive symptoms, CES-D >16, n (%)
History of depression, n (%)
History of anxiety, n (%)
History of cerebrovascular accident, n (%)
Diabetes, n (%)
Mean systolic blood pressure, mmHg (S.D.)
Mean diastolic blood pressure, mmHg (S.D.)
No grief 
(n = 4731)
 
60.7 (8.6)
2529 (53)
 
446 (9)
3147 (66)
1062 (22)
 
3585 (76)
919 (19)
227 (4.8)
472 (10)
 
– 
– 
– 
– 
– 
28 (1.6)
285 (6)
341 (7.2)
309 (6.6)
85 (2.0)
258 (5)
139 (20)
81.7 (10.9)
Grief 
(n = 615)
 
62.4 (9.3)a
433 (70)a
 
74 (12)
405 (66)
123 (20)
 
497 (81)
95 (15)
23 (3.7)
70 (11)
 
127 (20)
35 (5.7)
177 (29)
90 (14)
186 (30)
28.1 (1.6)
64 (10)a,d
74 (12)a,d
69 (11)a,d
9 (1.5)
40 (6.5)a
142 (20)
81.5 (11.0)
Complicated grief 
(n = 155)
 
61.9 (8.1)
121 (78)b
 
16 (10)
103 (66)
36 (23)
 
134 (86)
16 (10)
5 (3.2)
17 (11)
 
40 (26)
25 (16)
36 (23)
22 (14)
32 (21)
27.7 (1.8)a,d
41 (26)b,d
29 (19)b,d
24 (16)b,d
4 (3.0)
14 (9)b
137 (19.7)
80.7 (11.7)
S.D., Standard deviation; N.A., not applicable; MMSE, Mini-Mental State Examination; CES-D, Center of 
Epidemiological Studies Depression scale.
Group comparisons were performed with χ2 or analysis of variance.
aComparison of no-grief participants with grief participants (p < 0.05). bComparison of no-grief participants with 
complicated grief participants (p < 0.05). cParticipants with MMSE <23 were excluded. dComparison of grief 
participants with complicated grief participants (p < 0.05).
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 Cognition, structural brain changes and complicated grief
In this population-based study we 
investigated whether persons with 
complicated grief differ in cognitive 
function and structural brain changes 
from participants with normal grief and 
a control group without grief. Compared 
with either normal-grief or no-grief 
groups, participants with complicated 
grief performed worse in domains of 
executive function, and information 
processing speed, and had a lower total 
brain volume as measured by structural 
brain imaging.
The few previous studies of bereavement 
and cognition demonstrated poorer 
memory performance and attention in 
persons with normal grief, but did not 
specifically examine complicated grief 
(Xavier et al. 2002; Ward et al. 2007; 
Rosnick et al. 2010; Corruble et al. 2011). 
Two other studies examined the emotional 
Stroop Test in persons with complicated 
grief, demonstrating that participants 
have more cognitive interference 
compared with no-complicated grief 
participants (Maccallum & Bryant, 2010; 
O’Connor & Arizmendi, 2014). However, 
the mechanisms supposedly underlying 
the association between normal grief 
and poor cognition may also explain our 
observations in persons with complicated 
grief. First, individuals with grief or 
complicated grief may perform worse 
in the cognitive tests because they find 
it more difficult to direct their attention 
(Maccallum & Bryant, 2010; Rosnick et 
al. 2010; O’Connor & Arizmendi, 2014). 
Interestingly, no differences in Stroop 
Tests 1 and 2 were observed between 
complicated grief participants and non-
grievers in the present study, suggesting 
that attention problems cannot easily 
explain our findings. However, we did 
not perform the emotional Stroop Test, 
which uses death-related and neutral cue 
words. Second, depressed mood, which 
is common in persons with normal grief, 
may interfere with cognitive performance 
in the bereaved (Boelen & Prigerson, 
2007). However, we excluded participants 
with major depression and adjusted our 
analyses for depressive symptoms.
Participants with complicated grief were 
characterized by more brain atrophy, 
whereas white matter lesion volumes, 
which reflect vascular brain damage, 
did not differ between those with 
complicated grief, normal grief or no 
grief. We argue that the absence of specific 
compartmental differences between the 
groups is most likely due to a non-specific 
process in participants with complicated 
grief. Our study cannot establish the 
temporal sequence, but if this is not a 
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chance finding, our results suggest that 
differences in structural brain volumes 
are linked to complicated grief.
The observed brain volume loss could be 
a consequence or a precipitating factor 
of complicated grief. If poorer cognitive 
performance in persons with complicated 
grief is a consequence of the brain loss, 
the observed atrophy may reflect a 
vulnerability to developing complicated 
grief. This interpretation is in accordance 
with the results of the cognitive testing. 
The Word Fluency Task is considered to 
be related to the intact function of the 
frontal cortices and the medial temporal 
areas (Pihlajamäki et al. 2000; Funahashi, 
2001), and the LDST is sensitive to brain 
dysfunction (Lezak et al. 2004). 
The Word Fluency Task and LDST were 
affected most in persons with complicated 
grief. In our study, participants with 
complicated grief had lower brain 
volumes. It is recognized that as people 
get older, their brain volume decreases 
and that different brain regions decrease 
in volume at different rates (Romanowski 
& Wilkinson, 2011). The brain volume 
decrease implies neuronal loss that may 
disrupt the microstructural integrity of 
the fascicles connecting the prefrontal 
cortex with the cortical (frontal, temporal 
and occipital lobes) and the subcortical 
areas (amygdala and hippocampus), and 
even in the functioning of corticostriatal 
circuitry (Elliot, 2003; Shimada et al. 
2012). 
A lack of cerebral connectivity could 
explain a more prolonged resolution of 
grief in older adults as well as the poor 
performance in cognitive tests.
Alternatively, cognitive impairment 
may be a consequence of complicated 
grief. Recently a study showed that the 
regional brain activation to grief cues 
frequently includes the dorsal anterior 
cingulate cortex and the insula, as 
well as the posterior cingulate cortex 
(O’Connor, 2012). Some researchers 
have proposed that the anterior cingulate 
cortex, specifically the anterior cingulate 
gyrus, is part of an executive attention 
network, and its main role is to regulate 
the processing of information from other 
networks, both sensory modalities, and 
emotional (Ochsner & Gross, 2005; 
Posner & Rothbart, 2007; Posner et al. 
2007; Nelson et al. 2010; Pearson et al. 
2011). The regional neural activation of 
the dorsal anterior cingulate gyrus, insula, 
and posterior cingulate cortex in persons 
with complicated grief could cause a 
deregulation in the network processing 
the information.
Complicated grief is also perceived as a 
continuous and chronic stress. Chronic 
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stress has long-lasting negative effects 
on cognitive performance (Rosnick et al. 
2010). This stress can act in two forms: 
first, precipitating the neuronal loss and 
resulting in atrophy of the brain and 
cognitive decline. Second, glucocorticoids 
can cause a pronounced loss of synapses 
which are independent of volume brain 
loss, producing a disconnection among the 
brain areas (Tata et al. 2006). Importantly, 
these explanations for the possible causal 
process need not be exclusive.
In our study, we found no differences in 
cognition and structural brain changes 
between persons with normal grief 
and the controls. These findings were 
not unexpected if one views grief as 
a normal life event, unrelated to pre-
existing vulnerabilities such as structural 
brain volume loss. The previous studies 
finding poorer cognition in participants 
with normal grief could be explained by 
the lack of distinction between normal 
grief and complicated grief; i.e. previous 
studies combined persons with normal 
grief and complicated grief.
Strengths of our study include the very 
large sample size, the population-based 
setting and the volumetric quantification 
of brain tissue volumes. A control group 
of non-grieving persons was used to 
provide a contrast to participants with 
normal grief and those with complicated 
grief. Also, we controlled for clinically 
relevant depressive symptoms and 
excluded persons with major depression.
Some limitations of the current study 
should also be mentioned. First, it is not 
possible to evaluate if these associations 
were causal due to the cross-sectional 
design of the study. Second, we used a 
slightly modified version of the original 
ICG. Third, we focused on selected 
cognitive domains (e.g. global, memory, 
information processing speed, and 
executive function), and could not 
examine cognitive domains such as 
visuospatial processing, visuoperceptual 
tasks, or naming. Fourth, we studied 
global tissue volumes, but not subcortical 
or lobar tissue volumes. Fifth, we could 
not examine if complicated grief was 
associated with poorer self-care or if there 
were nutritional deficiencies.
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Conclusion
In conclusion, we found that participants 
with complicated grief had poorer 
cognitive performance than non-grievers 
and normal grievers, and lower total 
brain volume than non-grievers. Our 
study underscores the importance of 
assessing social, neuropsychological 
and biological factors that may underlie 
the occurrence of complicated grief or 
may result from prolonged exposure 
to a normal grief reaction. The 
neuropsychological differences between 
persons with and without complicated 
grief were more modest than in clinical 
studies (Xavier et al. 2002; Ward et al. 
2007; Maccallum & Bryant, 2010; Rosnick 
et al. 2010; Corruble et al. 2011; O’Connor 
& Arizmendi, 2014). 
Thus, any clinical implications must 
be inferred cautiously. We suggest that 
physicians should monitor patients 
who are in a prolonged grieving process 
closely and test these persons for possible 
cognitive deficits. Our analyses with a 
cut-off of 30 showed a more marked 
difference between participants with 
complicated grief and persons without 
grief, suggesting that clinical definitions 
of complicated grief describe a cognitively 
more compromised group. Support 
techniques for complicated grievers 
could include cognitive support and 
treatment or prevention of vascular risk 
factors, as these can slow the process of 
brain atrophy. Similarly, patients with 
known cognitive deficits should be 
offered support for cognitive problems 
in addition to psychological and social 
support if confronted with the loss of a 
loved one to prevent complicated grief.
We carefully controlled for cognitive 
decline by adjusting for the MMSE 
score. However, our results suggest that 
complicated grief, like severe depressive 
symptoms, may in some persons be 
prodromal of dementia. To address the 
temporality of the associations observed, 
we are planning to follow the participants 
and conduct a longitudinal study of the 
cognitive changes in participants with 
complicated grief.
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Objective: Bereavement can result in 
unresolved and prolonged grief, often 
termed prolonged grief disorder (PGD).The 
impact of PGD on cognitive functioning is 
poorly understood. The aim of the study 
was to compare the cognitive decline, 
assessed by repeated measures of different 
cognition domains, between persons with 
normal and PGD and a non-grieving 
reference population in a 7-year follow-up 
study. 
Methods: The study sample comprised 
3126 non-demented persons, mean age: 64 
years, of the Rotterdam Study. Participants 
were classified into three groups: no grief 
(reference group, N = 2,582), normal grief 
(N = 418), and prolonged grief disorder 
(N = 126). Partici-pants were assessed 
with the Complicated Grief Inventory and 
underwent cognitive testing (Mini-Mental 
State Examination [MMSE], Letter-
Digit Substitution test, Stroop test, Word 
fluency task, Word learning test). Analyses 
were adjusted for baseline cognition and 
depressive symptoms; persons with major 
depressive disorders were excluded.
Results: Compared with the reference 
group, participants with PGD showed 
a decrease in global cognitive function, 
MMSE scores, and World learning test 
(immediate and delayed) over time. 
Participants with normal grief did not 
show a stronger cognitive decline in any of 
cognitive tests than the reference group. 
Conclusions: Participants with PGD 
showed a stronger cognitive decline than 
the reference group during 7 years of follow-
up.This suggests that PGD is a risk factor 
for cognitive decline, but this study cannot 
detect the psychobiological mechanism 
underlying this longitudinal association. 
(Am J Geriatr Psychiatry 2018; 26:451–
460).
Key Words: Grief, prolonged grief 
disorder, cognition, cognitive decline, 
elderly persons, population-based
Highlights
• Bereavement can result in 
unresolved and prolonged grief.
• Prolonged grief is defined as 
present when mourners have 
symptoms of separation distress 
(e.g., yearning, searching) and 
traumatic distress (e.g., disbelief, 
troubling accepting the death, 
bitterness) for at least 6 months, 
to the point of functional 
impairment.
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• Prolonged grief is a condition that 
has a great impact on the quality 
of life, but the impact of prolonged 
grief on cognitive functioning is 
poorly understood.
• The aim of the current study was 
to compare the cognitive decline, 
assessed by repeated measures 
of different cognition domains, 
between persons with normal 
and prolonged grief, and a non-
grieving reference population in a 
7-year follow-up study.
• Our results demonstrate that 
prolonged grief is a risk factor for 
cognitive decline.
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INTRODUCTION
The human reaction to bereavement is 
characterized by a variety of feelings, 
thoughts, and behaviors, of which 
grief is regarded as the most common.1 
Grief may have negative consequences 
that typically resolve within months, 
including exacerbation of preexisting 
levels of depression,2 increased risk 
of suicide,3 physical health problems, 
higher rates of disability, medication use, 
hospitalization,4 and possibly a short-
term decline in cognitive functioning.5–8 
Unresolved and prolonged grief is also 
observed in some individuals.
Prolonged grief disorder (PGD) is 
defined as a clinical condition present 
when mourners have symptoms of 
separation distress (e.g., yearning, 
searching) and traumatic distress (e.g., 
disbelief, troubling accepting the death, 
bitterness) for at least 6 months, to 
the point of functional impairment.9 
The disorder occurs in about 5% to 
25% of the population experiencing 
bereavement, but the prevalence varies 
with age and social, cultural, and clinical 
background.10,11 The symptoms of PGD 
are distinct from those of depression 
and anxiety,12–14 despite high levels of 
comorbidity. PGD is a condition that 
has a great impact on quality of life,15,16 
and has been related cross-sectionally to 
sleep disturbances17 and a higher risk of 
suicidal ideation.18 Prospectively, it has 
been related only to depression, anxiety,15 
and deteriorating health.16
The impact of the PGD on cognitive 
functioning, in particular, is not well 
known. Several studies investigated the 
relation of (acute) grief with cognitive 
impairment,6–8 but few researchers have 
examined the impact of PGD on cognitive 
decline. Recently, a longitudinal study of 
1,138 participants with 6 weeks of follow-
up compared cognitive impairment 
between bereaved subjects and major 
depressive disorder (MDD) subjects. 
The authors observed that in both 
groups memory performance declined 
(immediate and delayed recall) during 6 
weeks of follow-up.6
Two cross-sectional studies also showed 
that bereaved persons performed worse 
in cognitive tests than non-bereaved 
persons. One of these, a study of 211 
older adults, found that bereavement 
was associated with poorer memory 
performance in men7; the other study 
showed that bereaved persons performed 
worse in tests of attention, information 
processing speed, and verbal fluency.8
Recently, in a cross-sectional study 
of 5,530 participants, we showed that 
persons with PGD had lower scores 
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for executive function and information 
processing speed function when 
compared with those with normal grief. 
Participants with PGD also had smaller 
total brain volumes, suggesting that pre-
existing brain changes may contribute to 
the occurrence of PGD.19
The temporal relation between grief 
and cognition could not be determined, 
however. Whether cognitive function 
in persons with PGD declines over the 
time remains to be studied. The aim of 
the current study was to compare the 
cognitive decline, as assessed by repeated 
measure of different cognition domains, 
between persons with normal grief 
and PGD and a non-grieving reference 
population in a 7-year follow-up study. We 
hypothesized that participants with PGD 
will experience a cognitive decline during 
follow-up, in contrast to participants with 
normal grief, who will not differ from the 
non-grieving reference group.
METHODS
Study Participants
The current study is based on the 
Rotterdam Study, a large prospective 
population-based cohort designed to 
examine the occurrence and risk factors 
of chronic diseases. The study has been 
described in detail elsewhere.20 The 
medical ethics committee of the Erasmus 
University of Rotterdam approved the 
study, and informed consent was obtained 
from all participants. The current study 
combines two cohorts from the Rotterdam 
Study. The first was the original cohort, 
which commenced in 1990–1993. At 
this time all in-habitants aged over 55 
years living in the Ommoord district of 
Rotterdam were invited to participate; of 
these, 7,983 (78%) participated. In 2000, 
people who had become 55 years of age or 
moved into the study district were added 
as a second cohort of 3,011 (67% response 
rate) participants.
The measurement of PGD through the 
Inventory of Complicated Grief (ICG) 
was introduced in the fourth follow-up 
examination (2002–2004) of the original 
cohort and in the second follow-up 
examination of the additional cohort (2004–
2005). These two examination rounds were 
identical across the cohorts and constitute 
the baseline. All data for this study were 
collected during an interview at the 
participants home. The baseline interview 
comprised 5,939 participants. For the 
present study we selected participants with 
no grief, participants with grief (ICG <22), 
and with PGD (ICG ≥22). Participants with 
Mini-Mental State Examination (MMSE) 
scores less than 23 (N = 689), with MDD 
(N = 91), or with incomplete cognitive tests 
(N = 211) were excluded. Of the remaining 
4,948 participants, 4,750 completed the 
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ICG. These 4,750 non-demented elderly 
persons aged over 55 years (mean age: 65 
years, 57% women) were included in the 
cross-sectional analyses at baseline.
From March 2009 to July 2012 we 
reinvited 4,580 of the participants for a 
second examination (170 died). From 
these 4,580 participants, 66 persons did 
not participate because of complaints 
of physical symptoms, 123 became 
demented, 56 could not be contacted, 
94 had moved outside Rotterdam, 350 
refused to participate in the interview 
without reasons, 230 did not undergo 
cognitive testing during follow-up 
examination, and 535 had incomplete 
cognitive test. This resulted in 3,126 
non-demented elderly people for follow-
up analysis. Participants who were 
not assessed at follow-up were older, 
less educated, had more depressive 
symptoms, higher blood pressure, and a 
lower MMSE score than those included.
Assessment of Prolonged Grief
All participants were asked if in the past 
someone had died who they still mourn. 
If the answer was positive, we asked 
formal follow-up questions: “When did 
this person die?” and “Who was this 
person?” The last question had several 
answer options (spouse, partner, parent, 
child, brother, sister, another family, good 
friend, other, or several persons). 
The participants who answered the first 
question affirmatively were assessed for 
PGD with the Dutch version of the ICG.
At least six months of duration of 
symptoms was required in accordance 
with recommendations for diagnostic 
criteria and to exclude an acute stress 
reaction.21 Questions represent symptoms 
of PGD on the basis of the most recently 
proposed criteria. The ICG is considered 
the criterion standard for measurement 
of PGD in older adults because it has high 
internal consistency, good convergence, 
and criterion validity.22 The inventory 
represents a single underlying construct 
of PGD. As described before,10 17 
questions were asked and responses were 
provided on a 5-point scale to reflect an 
increase in severity (0-never, 1-seldom, 
2-sometimes, 3-often, and 4-always). 
In the current setting, one item, “I feel 
bitter over this person’s death”, was 
removed from the original inventory as 
a pilot study revealed that this sentiment 
had a very similar meaning within the 
Dutch language as the included item: “I 
feel anger over this person’s death”. Two 
further items (relating to seeing and 
hearing the deceased) were combined 
into one because of their similarity and 
a pilot study indicating these symptoms 
were low in frequency and too often 
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overlapped (“I hear the voice of or see the 
person who died”).
A summary score for the ICG was 
calculated by totaling each individual 
item score (responses from 0-never to 
4-always) across the 17-items providing 
a potential score range of 0 to 68. We 
defined PGD based on the severity of 
symptoms. Participants with an ICG 
score of less than 22 were classified as 
“normal grievers”, in line with previous 
studies.10 
Participants with a score of 22 or greater 
due to bereavement experienced at least 
6 months before were considered to have 
PGD. Participants with an ICG score 
of 22 or greater who had been grieving 
for less than 6 months were classified 
as participants with normal grief. This 
cut-off was based on the cut-off in the 
original version of the ICG (original 
cut-off of 25 from 19 items). Thus we 
classified participants into three groups: 
no grief (reference group), persons with 
normal grief (experiencing no prolonged 
grief as shown by an ICG score <22) and 
those with PGD (ICG score ≥22). 
The non-grieving reference group 
included persons who had experienced 
bereavement in the past but were not 
grieving at the time of interview. Likewise, 
persons mourning a pet or someone with 
severe disease who was still alive were 
included in the reference group.
Assessment of Cognitive Decline
Participants underwent the same 
neuropsychological tests at the baseline 
and at the follow-up examinations: the 
MMSE, the Stroop test, the Letter-Digit 
Substitution Task (LDST), the Word 
Fluency Task (WFT), and a 15-word 
verbal learning test (WLT). For each 
participant, we calculated z-scores for the 
tests at baseline and follow-up, except for 
the MMSE. We constructed a compound 
score for global cognitive function as the 
average of all individual tests except the 
MMSE.23
The MMSE is a widely used test for 
screening for dementia and it provides 
a reliable measure of global cognitive 
functions. Scores on this test range from 
0 to 30, with higher scores indicating a 
better cognitive performance.23
The LDST was used to measure processing 
speed. Participants make as many letter 
digit combinations as possible within 60 
seconds, following an example that shows 
the correct combinations.23
The Stroop Test measures attention and 
concentration and consisted of three 
trials. In trial 1, the card contains color 
names printed in black and participants 
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are asked to name the printed word. In 
trial 2, the card contains colored blocks 
and participants are asked to name the 
printed color. In trial 3, the card contains 
color names printed in a different color 
than the color name and participants are 
asked to name the color of the ink. The 
outcome variable is the time needed to 
finish the trial.23 The WFT was used to 
test verbal fluency. Participants are asked 
to name as many animals as possible 
within 60 seconds.23 
The WLT tests memory functions with 
immediate recall and delayed recall 
components. Participants are given a list 
of 15 unrelated words repeated over five 
different trials and are asked to repeat 
them. Another list of 15 unrelated words 
is given and the participant is asked again 
to repeat the original list of 15 words and 
again after 30 minutes.24
Assessment of Other Variables
Potential confounders were selected on 
the basis of previous publications, and 
included important determinants of grief 
or cognitive decline.6–8 Information was 
collected in home interviews and during 
physical examination at baseline.20 The 
following variables were tested as possible 
confounders: age (continuously per year), 
sex, level of education, blood pressure, 
diabetes mellitus, cerebrovascular accident 
history, and depressive symptoms.
Except age and sex, all variables were 
imputed. The missing covariate values, on 
average less than 2%, were imputed using 
median imputation.
Level of education was assessed during 
the home interview and was classified 
into primary education only, intermediate 
education, and high education 
(university studies). Blood pressure 
was measured twice at the right arm in 
a sitting position using a random-zero 
sphygmomanometer. The average of the 
two values measured at one occasion was 
used. Diabetes mellitus was defined as a 
fasting serum glucose level of 7.0 mmol/L 
or greater and/or the use of blood glucose-
lowering drugs. A cerebrovascular 
accident was defined according to 
World Health Organization criteria as a 
syndrome of rapidly developing clinical 
signs of focal (or global) disturbance of 
cerebral function, with symptoms lasting 
24 hours or longer or leading to death, 
with no apparent cause other than of 
vascular origin. Depressive symptoms 
were assessed with a validated Dutch 
version of the Centre for Epidemiologic 
Studies Depression (CES-D) scale 
(range: 0–60).25 Scores of 16 or greater 
are interpreted as suggestive of clinically 
significant depressive symptoms. In 
addition to adjustment for depressive 
symptoms, participants with MDD at 
baseline were excluded based on previous 
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studies showing that symptoms of PGD 
are distinct from those of depression but 
that there is very substantial comorbidity 
between PGD and MDD.12–14 To this aim, 
all participants with clinically relevant 
depressive symptoms (CES-D score 
≥16) were interviewed using the Present 
State Examination, a semistructured 
psychiatric interview included in the 
Schedules for Clinical Assessment in 
Neuropsychiatry. All interviews were 
conducted by one of two experienced 
clinicians. Major depression was 
classified according to the Diagnostic and 
Statistical Manual of Mental Disorders, 
Fourth Edition.26
Statistical Analysis
We investigated the association of PGD 
with measures of cognitive performance. 
We evaluated the cognitive performance 
on different levels of aggregate: 
global cognitive measures (global 
cognitive function and MMSE), and 
we also analyzed the associations with 
individual cognitive tests (LDST, WFT, 
Stroop test, and WLT immediate and 
recall). Information on demographic 
characteristics was compared among the 
groups using a χ2 test for categorical data 
and an analysis of variance for continuous 
variables.
First, we investigated the cross-sectional 
baseline association of PGD with the 
measures of cognitive performance. To 
this aim, we compared the scores of the 
reference group to those participants with 
normal grief and to those of participants 
with PGD using analysis of covariance 
(ANCOVA).
Second, we investigated the longitudinal 
association of PGD with the cognitive 
performance change with linear 
regression. We examined the association 
of grief and PGD with cognitive change 
defined by the global cognitive measures 
and the individual tests. We tested the 
difference in cognitive decline over the 
follow-up period between persons in the 
reference group and those with normal 
grief as well as the difference between 
persons in the reference group and those 
with PGD.
The analyses were adjusted for age and 
sex, level of education, blood pressure, 
diabetes, history of cere-brovascular 
accident, depressive symptoms (CES-D), 
and the score on the respective baseline 
cognitive measure. The adjustment 
for baseline cognition maximizes the 
statistical power in the analyses of 
cognition at follow-up and is considered 
a more reliable method than difference 
scores and percentage change.27 We also 
calculated the effect size of the associations 
using Cohen’s d. We performed a non-
response analysis to evaluate if participants 
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not assessed at follow-up significantly 
differed from those included at baseline.
Several sensitivity analyses were 
conducted. First, we additionally adjusted 
for antidepressants, psychostimulants, and 
antidementia drugs, as these medications 
may be prescribed subsequent to the 
occurrence of grief but can also confound 
results. Second, we additionally adjusted 
for anxiety disorders. Anxiety disorders 
were diagnosed with an adapted version 
of the Munich version of the Composite 
International Diagnostic Interview.28 
Third, we performed analyses including 
participants with MDD. Fourth, we tested 
a time frame of 12 months instead of 6 
months since loss as criterion to diagnosis 
PGD.
We used the SPSS statistical package 
(IBM, Armonk, NY) to perform our 
analyses. Two general hypotheses were 
tested, and p values were Bonferroni-
corrected accounting for the three 
groups. were tested, and p values were 
Bonferroni-corrected accounting for the 
three groups.
RESULTS
Table 1 presents the characteristics 
of the study sample for longitudinal 
analysis. The longitudinal study sample 
comprised 2,582 people with no grief 
(reference group), 418 with normal grief, 
and 126 with PGD. The mean age of the 
participants at baseline was 64 years (SD: 
5.3) and 58% were women. Supplemental 
Table S1 provides the characteristics of 
the sample in the cross-sectional analyses.
Table 1 show that the main cause for 
bereavement in those with prolonged 
grief was death of a partner (49%), 
followed by the death of a child (19%). 
In participants with normal grief this 
was death of a partner (27%) and 
brothers/sisters (20%). Participants with 
prolonged grief more often had diabetes, 
history of a cardiovascular event, and 
clinically relevant depressive symptoms 
than persons with normal grief. No 
differences were found in any of the other 
characteristics.
Table 2 shows the cross-sectional 
association of cognitive test scores across 
the three groups at baseline, which we 
tested with ANCOVA. Participants with 
PGD had lower scores in the LDST 
compared with the reference group 
without grief. Participants with normal 
grief had lower scores on the Stroop 
test than the reference group. No other 
differences were found at baseline.
Next, we examined the cognitive decline 
in these participants over on average 7.3 
years with ANCOVA. Table 3 shows the 
decline in the different cognitive test 
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scores across the three groups at follow-up. 
Participants with PGD showed a stronger 
decrease in global cognitive function 
and MMSE scores than the reference 
group. Participants with PGD had a 
particularly strong decline in the WLT 
(immediate and delayed). Participants 
with normal grief did not show a stronger 
decline in any of the cognitive tests if 
compared with the reference group. We 
also compared participants with PGD to 
those with normal grief. Participants with 
PGD showed a greater decline in MMSE 
(F(1,531) =3.869, p < 0.05) and in the 
WLT (delayed recall) (F(1,413) = 4.108, 
p < 0.04) across follow-up than persons 
with normal grief. We did not observe any 
difference over time between persons with 
normal grief and persons with PGD in any 
of the other cognitive tests.
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We compared the Cohen’s d between 
participants with PGD and the reference 
group on global cognition (Cohen’s d = 
0.21), MMSE (Cohen’s d = 0.17), WLT 
delayed (Cohen’s d = 0.20), and WLT 
immediate (Cohen’s d = 0.17). These 
effect sizes must be considered small. 
Participants that were not assessed at 
follow-up were older, less educated, had 
more depressive symptoms, higher blood 
pressure, and a lower MMSE score than 
those included.
We performed several sensitivity 
analyses. First, we additionally adjusted 
the analyses for antidepressants, 
psychostimulants, and anti-dementia 
drugs. The results remained essentially 
unchanged, all associations with cognitive 
tests remained except that between the 
WLT immediate and prolonged grief 
(F(1,2128) = 3.372, p < 0.06). In another 
sensitivity analysis we adjusted for anxiety 
disorders. Compared with the reference 
group, participants with PGD no longer 
showed a significantly stronger cognitive 
decline in MMSE score (F1.26=3.713, 
p<0.05). 
The other associations remained. We 
performed a third sensitivity analysis 
in which we included 91 participants 
with MDD. The results only very 
marginally changed, although again some 
associations were no longer significant.
Participants with PGD did not show 
a significant global cognitive change 
(F(1,1976) = 2.746, p < 0.09) or an MMSE 
score decline (F(1,2734) = 3.385, p < 0.06).
We also tested a timeframe of 12 months 
since loss as criterion to diagnose PGD. 
Compared with the reference group, 
participants with PGD did not show a 
cognitive decline in MMSE score in these 
additional adjusted analyses (F(1,2682) 
= 1.61, p < 0.20). This difference partly 
reflects a reduced effect size and reduced 
power as fewer people had complicated 
grief with this more stringent definition. 
The other results did not change 
meaningfully.
DISCUSSION
In this population-based study of middle-
aged and older persons, we showed that 
participants with PGD were, on average, 
more likely to have a decline in global 
cognitive functioning over 7 years follow-
up than participants with no grief.
A few previous cross-sectional studies of 
bereavement and cognition demonstrated 
poor memory performance and attention 
in persons with normal grief.
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However, none of these studies examined 
cognitive decline or assessed PGD.5,6 
These results are typically interpreted 
as cognitive impairment due to grief. 
Our baseline analyses suggest that such 
findings may largely be accounted for by 
persons with severe or PGD. Our study 
also indicates that in cross-sectional 
studies reverse causality cannot easily be 
ruled out that is, those with pre-existing 
cognitive problems cannot cope with 
grief. At baseline, the participants with 
PGD already performed poorly in the 
Letter-Digit Substitution Task.
The mechanisms underlying the 
association between PGD and poor 
cognition are not clear, but several 
explanations must be discussed. First, 
bereaved individuals may perform worse 
in the cognitive tests because they find it 
more difficult to direct their attention to 
the tests. There is evidence that persons 
with PGD find it particularly difficult to 
concentrate and suffer from intrusive 
negative thoughts, which interfere with 
attention and performance during 
testing.29
Also, they may utilize their attention 
resources during cognitive tests, to try 
to suppress intrusive and unwanted 
thoughts.7 Likewise, depressed mood may 
interfere with cognitive performance in 
the bereaved.15,30 However, we excluded 
participants with MDD and adjusted our 
analyses for depressive symptoms.
Second, because of the persistence of 
the bereavement symptoms and the 
resistance of the related psychological 
problems to treatment and to non-
medical interventions, PGD subjects 
the bereaved person to high levels of 
stress.31–33 Sustained levels of stress 
produce activation of the hypothalamic-
pituitary-adrenal axis with an increase 
of glucocorticoids concentrations, 
which have been linked to a reduction 
of the hippocampal volume.34–37 The 
hippocampus is essential for many types 
of memory, such as episodic memory and 
spatial memory.38,39
Third, the observed memory decline 
may be due to a pre-existing cognitive 
impairment40 that could make a grieving 
person more vulnerable to develop PGD. 
To offset for this, we adjusted for baseline 
MMSE scores and excluded persons 
with scores below 23. This means that 
any pre-existing cognitive impairment at 
baseline must have been very subtle and, 
for example, an early stage of any mild 
cognitive impairment (MCI).
In our study, we showed an overall 
decline in global cognitive function and 
MMSE but also observed that the WLT 
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(both immediate and delayed recall) 
contributed strongly to the observed 
decline of the global cognition.
In contrast, participants with PGD 
experienced no further decline in the 
performance in the LDST, WFT, or the 
Stroop test over the 7-year follow-up 
period. This finding can be carefully 
interpreted as supporting MCI in those 
with PGD. Studies have shown that 
the delayed recall battery has a high 
sensitivity and specificity to differentiate 
early stages of cognitive impairment 
from cognitive performance in normal 
elderly, and is more accurate than the 
MMSE.41–43 In particular, total immediate 
recall and delayed recall were found to 
be robust predictors of MCI converting 
to Alzheimer disease within 3 years of 
follow-up.44
The estimated effect sizes in our study 
were small, implying that PGD by itself 
is not a major cause of cognitive decline 
and should not be a focus of intervention 
in all grieving persons but probably 
contributes meaningfully to cognitive 
impairment only in vulnerable persons.
We did not find any further decline in 
cognitive functioning in this longitudinal 
study of participants with only normal 
grief. These findings were in line with 
our hypothesis, that grief is a normal 
life event, unrelated to pre-existing 
vulnerabilities, from which the majority 
of the persons recover.
The findings of previous studies showing 
poor cognition in participants with 
normal grief might be explained by 
the lack of distinction between normal 
grief and PGD in their population.6–8 
These studies jointly analyzed persons 
with normal grief and PGD, who are 
characterized by more severe symptoms. 
Also, these studies mostly did not exclude 
or adjust for MDD, which is strongly 
related to poor cognitive performance 
and grief severity.
A strength of our study is the very large 
sample size and the population-based 
setting. A reference group of non-grieving 
persons was used to provide a contrast to 
participants with normal grief and those 
with PGD. We controlled for depressive 
symptoms and history of cerebrovascular 
accident. Some limitations of the current 
study should also be mentioned. First, 
34% of the baseline group of participants 
had no follow-up assessment, but this is 
not uncommon in prospective studies of 
elderly people.45 Second, we used a single 
question to screen for possible grief. This 
may introduce some misclassification, 
although a detailed history of all 
meaningful persons lost in this elderly 
population was not feasible and may 
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also introduce recall bias with regard to 
mourning. Third, we did not assess grief 
symptoms at follow-up and thus cannot 
establish whether PGD, which persisted 
at follow-up, explains the findings.
Fourth, we focused on selected cognitive 
tests, and could not examine cognitive 
domains such as visuospatial processing, 
visuoperceptual tasks, or naming. 
Fifth, we used a static imputation as the 
frequency of missing data was very low, 
although this can marginally reduce the 
standard error.
In our study, we found a decline in global 
cognitive function, MMSE, and the 
WLT (immediate and delayed recall) in 
participants with PGD. The measure of 
the effect size for each cognitive test was 
small. The decline in the delayed-recall 
component of the WLT was most marked. 
Our results suggest an association 
between PGD and cognitive decline, but 
we cannot infer causality from this study 
or detect the psychobiological mechanism 
underlying this longitudinal association. 
Also, we cannot conclude whether PGD 
persistent across the follow-up period 
underlies the observed results. PGD has a 
high incidence in any elderly population, 
as more than 30% of all women and 10% 
of men lose a partner.46 In our study, we 
found that the prevalence of PGD in 
the sample was 4%, and the prevalence 
of PGD in the grieving population was 
23%. Our findings suggest that physicians 
should closely monitor patients who are 
in a prolonged grieving process, test these 
persons for possible cognitive deficits, and 
consider cognitive support techniques for 
the most vulnerable persons. Similarly, 
patients with known cognitive deficits 
should be offered additional psychological 
and social support if confronted with the 
loss of a loved one to prevent PGD.
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Objective/Background: About 15% 
of grievers experience complicated 
grief. We determined cross-sectional 
and longitudinal relations of grief and 
complicated grief with sleep duration 
and quality in the general population of 
elderly adults. 
Participants: We included 5,421 men and 
women from the prospective population-
based Rotterdam Study. 
Methods: The Inventory of Complicated 
Grief was used to define grief and 
complicated grief. We assessed sleep with 
the Pittsburgh Sleep Quality Index. 
Results: After 6 years, 3,511 (80% of 
survivors) underwent the follow-up 
interview. Complicated grief was cross-
sectionally associated with shorter sleep 
duration and lower sleep quality. These 
associations were explained by the 
presence of depressive symptoms. The 
prospective analyses showed that sleep 
duration and sleep quality did not decline 
further during follow-up of persons who 
experienced grief or complicated grief. 
Conclusion: In community-dwelling, 
middle-aged and older adults, persons 
with normal and complicated grief 
had both a shorter sleep duration and 
a lower sleep quality, mainly explained 
by depressive symptoms. However, 
prospective analyses showed that sleep 
quality and sleep duration do not decline 
further in persons with normal grief and 
complicated grief.
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The death of a loved one is a common life 
event in older adults (Boelen & Hoijtink, 
2009; Boelen& van den Bout, 2008; M. K. 
Shear, 2015). Very few persons make it 
through old age without having to cope 
with this kind of loss, once or several 
different times. 
The loss of a partner, child, parent, 
or close family member can be very 
distressing (Monk, Germain, & Reynolds, 
2008). However, even if it is experienced 
as a traumatic event, after a delimited 
period of grief, the majority of people 
recover. An estimated 15% of bereaved 
people continue to grieve for an extended 
period; they experience disbelief and are 
preoccupied by the deceased (Prigerson 
et al., 1995). This state is known as 
complicated grief (Prigerson et al., 2009). 
Complicated grief is an important mental 
health issue for the aging population, 
affecting social functioning and well-
being (Newson, Boelen, Hek, Hofman, & 
Tiemeier, 2011). However, our knowledge 
about complicated grief is limited. 
Previous studies suggest that symptoms 
of complicated grief are distinct from 
those of depression and anxiety and 
have incremental validity predicting 
impairments in social and interpersonal 
daily functioning (Boelen, van de Schoot, 
van den Hout, de Keijser, & van den Bout, 
2010; Newson et al., 2011; Prigerson & 
Jacobs, 2001). In addition, the severe 
emotional strain of the loss of a loved one 
can trigger profound changes in lifestyle. 
These changes often induce reductions 
in financial security, perceived personal 
safety, and freedom of action. All of these 
facets of grief could lead to changes in 
sleep patterns. Several studies (Hall et 
al., 1997; Kowalski & Bondmass, 2008; 
Monk, Begley, et al., 2008) suggest that 
grief is associated with significant sleep 
impairment. However, our knowledge 
regarding the associations of complicated 
grief with sleep is limited, as only a few 
studies with small sample size and a cross-
sectional design have been conducted 
(Boelen & Lancee, 2013; Germain, Caroff, 
Buysse, & Shear, 2005; Maytal et al., 
2007; Monk, Begley, et al., 2008; Purebl, 
Pilling, Konkoly, Bodizs, & Kopp, 2012; 
Spira, Stone, Beaudreau, Ancoli-Israel, 
& Yaffe, 2009). An exploratory study of 
the effects of complicated grief on sleep 
by McDermott et al. (1997) conducted 
analyses on 65 bereaved persons. 
The results showed mild subjective sleep 
impairment is associated with complicated 
grief, but no effect was detected using 
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the electroencephalographic sleep 
measures. Germain et al. (2005) evaluated 
the severity of sleep disturbances in a 
group of 105 adults meeting criteria 
for complicated grief. They showed an 
association of complicated grief with 
an overall poor sleep quality. Comorbid 
depression (Adrien, 2002; Germain et al., 
2005; Hall et al., 1997; Maytal et al., 2007; 
Monk, Begley, et al., 2008; Nutt, Wilson, 
& Paterson, 2008; Purebl et al., 2012; Spira 
et al., 2009), but not posttraumatic stress 
disorder, further worsened sleep quality.
Taking into account the lack of high-
powered longitudinal studies in normal 
populations of elderly adults, we aim to 
Settings and Study Population
This study was embedded in The 
Rotterdam Study, an ongoing prospective 
cohort of older adults designed to examine 
the occurrence and risk factors of chronic 
diseases. The study design and objectives 
are described in Hofman et al. (2013).
The Rotterdam Study comprises two 
cohorts, which were combined in the 
current analysis. Between 2002 and 2005, 
complicated grief and sleep quality were 
assessed during a home interview, referred 
to as baseline. The baseline interview was 
determine whether in adults aged 55 years 
and above, grief or complicated grief was 
related to sleep duration and sleep quality, 
cross-sectionally and longitudinally.
We hypothesized that if studied cross-
sectionally, persons with grief and 
complicated grief have shorter sleep 
duration and a lower sleep quality than 
persons who did not experience grief 
due to the stress that death of the loved 
one brings to person’s life. Second, we 
hypothesized that complicated grief 
remains a risk factor for further decline of 
sleep duration and poor sleep quality over 
time due to coping mechanisms that may 
not always be successful.
conducted in 5,481 participants. Of these 
participants, 60 persons did not complete 
the grief or sleep questionnaire. 
This left 5,421 participants with assessment 
of grief and sleep characteristics for 
cross-sectional analysis. In part of the 
follow-up examination (2009– 2011), 
both components of sleep (duration and 
quality) were assessed at the research 
center. After an average of 6.33 years 
(SD = 0.42), 3,511 (80%) of the 4,601 
surviving participants underwent the 
follow-up interview for sleep duration, 
METHODS
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and 3,003 (71%) for sleep quality. The 
Rotterdam Study has been approved 
by the Medical Ethics Committee of 
the Erasmus Medical Center (Erasmus 
MC) and by the Ministry of Health of 
the Netherlands, implementing the Wet 
Bevolkingsonderzoek: ERGO (Erasmus 
Rotterdam Gezondheid Onderzoek; 
Population Studies Act: Rotterdam 
Study). All participants provided written 
informed consent to participate in the 
study and to obtain information from 
their treating physicians.
Assessment of Complicated Grief
Complicated grief was diagnosed at the 
baseline examination (2002 and 2005), 
with a Dutch version of the 17-item 
Inventory of Complicated Grief (ICG) 
originally constructed by Prigerson 
et al. (which contains 19 items). First, 
participants were asked if they were 
currently grieving. If a positive answer 
was received, the ICG was administered, 
but if not, they were categorized as 
nongrievers (the reference group). The 
ICG is the most widely used instrument 
to measure complicated grief. 
Questions represent symptoms of 
complicated grief such as those in the 
most recent proposed criteria for the 
condition suggested by (Prigerson et al., 
2009). Some of the symptoms include 
intense yearning for the lost person, anger 
over the death, distrust and detachment 
from others as a consequence of the 
death, survivor guilt, and loneliness. The 
measure has high internal consistency 
and convergent and criterion validity 
and it is considered the gold standard 
for measurement of complicated grief in 
older adults. 
The inventory is shown to represent 
a single underlying construct of 
complicated grief (Boelen & Hoijtink, 
2009). The Dutch version of the Inventory 
of Complicated Grief contains 17 items 
and has been previously validated (Boelen 
et al., 2003). These 17 questions were 
asked and responses were provided on 
a 5-point scale to reflect an increase in 
severity (0-never, 1-seldom, 2-sometimes, 
3-often, 4- always). In the current study 
one item from the original inventory, 
“I feel bitter over this person’s death,” 
was removed from the original ICG 
because a pilot study revealed that this 
sentiment had the same meaning within 
the Dutch language as the included item, 
“I feel anger over this person’s death.” 
Two further items (relating to seeing and 
hearing the deceased) were collapsed into 
one due to their similarity and to a pilot 
study indicating these symptoms were 
low in frequency and often overlapped (“I 
hear the voice of, or see, the person who 
died”). Several studies give further details 
on the interpretation of ICG (Boelen et 
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al., 2010; Newson et al., 2011; Prigerson & 
Jacobs, 2001). 
We divided all interviewed participants 
into nongrievers (reference group), 
normal grievers, and complicated grievers. 
Complicated grief symptoms were 
assessed as present among participants 
who scored equal or greater than 22 on 
the ICG score and grieved longer than 6 
months (Newson et al., 2011; Saavedra 
Perez et al., 2015).
Assessment of Sleep
Sleep duration and sleep quality were 
measured with the Pittsburgh Sleep 
Quality Index (PSQI), a self-reported 
questionnaire (Buysse, Reynolds, Monk, 
Berman, & Kupfer, 1989). The PSQI 
consists of 19 self-rated questions. 
Questions are grouped into seven 
component scores, each weighted equally 
on a 0–3 scale. The seven component 
scores are then summed to yield a global 
PSQI score, which is used in all further 
analyses. This score has a range of 0–21; 
higher scores indicate worse sleep quality. 
The seven components are subjective 
sleep quality, sleep latency, sleep 
duration, habitual sleep efficiency, sleep 
disturbances, use of sleeping medications, 
and daytime dysfunction. In the current 
study, we used total sleep time in hours 
to indicate sleep duration, and a total 
score of PSQI to indicate sleep quality. 
Finally, we presented a sample of PSQI 
(Supplement A).
Assessment of potential confounders
Age, sex, education, cognitive functioning, 
activities of daily living, body mass index 
(BMI), and depressive symptoms were 
considered as potential confounders. 
Education was assessed routinely in the 
home interview and subdivided into 
low, intermediate, and high education. 
Cognitive functioning was measured 
using the Mini-Mental State Examination 
(Folstein, Folstein, & McHugh, 1975) 
during one of the visits to our center. 
The ability to perform activities of daily 
living was measured with the Stanford 
Health Assessment Questionnaire (Bruce 
& Fries, 2003; Fries, Spitz, & Young, 
1982). Height and weight were measured 
without shoes and heavy clothing to 
calculate the BMI (kg/m2). Depressive 
symptoms were measured with the Center 
for Epidemiological Studies Depression 
scale (CES-D). In our baseline table, we 
also showed the presence of depressive 
symptoms among participants who scored 
16 or above, suggesting clinically relevant 
depressive symptoms on the Center for 
Epidemiological Studies Depression scale.
Statistical Analyses
To explore the association between grief 
and sleep parameters we used linear 
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regression. Model 1 was adjusted for 
age and sex. Model 2 was additionally 
adjusted for education, cognitive 
functioning, activities of daily living, and 
BMI. Model 3 was further adjusted for 
depressive symptoms. In the longitudinal 
analyses, to examine whether grief status 
was prospectively associated with sleep 
duration and sleep quality, we used 
sleep duration and sleep quality assessed 
during the follow-up as outcomes. We 
selected the same covariates as in the 
cross-sectional analyses and adjusted for 
the respective baseline values of sleep 
duration or sleep quality.
We conducted a series of sensitivity 
analyses. First, we reran the analysis, not 
only for depressive symptoms, but to 
exclude all patients with major depression 
disorder at the baseline. We evaluated the 
presence of Major Depressive Disorder in 
those with a CES-D score, or above the 
established screening cutoff of 16, using 
the Schedules for Clinical Assessment 
in Neuropsychiatry (SCAN) interview 
(Wing et al., 1990). This semistructured 
clinical assessment was performed by 
trained clinicians to determine which 
participants fulfilled the DSM-IV major 
depressive disorder. We performed this 
sensitivity analysis in order to minimize 
the depressive disorders on sleep quality. 
Also, in our study, Major Depressive 
Disorder (MDD) was assessed at baseline 
only (prevalence of 2%). Second, to 
test the effect of the more recent sleep, 
we performed longitudinal analysis 
restricted to those who experienced 
the bereavement in the years prior to 
baseline assessment. Third, we repeated 
the cross-sectional linear regression 
only in those participants who had 
attended the follow-up assessment, to test 
whether any between cross-sectional and 
longitudinal analysis reflected a selection 
effect. Adjustments for these analyses 
were conducted as in the main linear 
regressions. Fourth, since sleep duration 
component of PSQI, we performed a 
sensitivity analyses calculating the PSQI 
total without the component of sleep 
duration. Fifth, in order to explore the 
possibility of reverse causality, in the 
longitudinal analysis, we excluded people 
who had poor sleep at the baseline (defined 
as the total score of all components of 
PSQI greater than 5 points). Sixth, we 
explore whether, cross- sectionally and 
longitudinally, sleep duration and sleep 
quality differ between grievers (reference) 
and complicated grievers. We also 
explored the association between grief 
status and depressive symptoms (CES-D). 
In multivariable linear regression models, 
we examined whether baseline grief status 
was prospectively associated with CES-D 
at follow-up, further adjusted for the 
baseline value of depressive symptoms.
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With respect to the remaining data, 
missing values were imputed using 
multiple imputations (Rubin, 2004). In 
the present study, for each missing value 
five draws were performed providing 
five substituted items of data, which in 
turn created five completed data sets. 
Analyses were performed separately on 
each completed data set and there after 
combined into one pooled estimate. The 
Of the 5,421 eligible participants, 4,378 
(80%) were classified as experiencing “no 
grief,” 795 (15%) as experiencing “normal 
grief,” and 248 (5%) as experiencing 
“complicated grief ” at baseline. Table 1 
presents the characteristics of the study 
population. Participants classified as 
experiencing complicated grief were 
older, were more likely to be female, 
percentage of missing values within the 
population for the analyses was lower than 
20% (ranging from 0 to 18%). Age and 
sex had no missing values, education had 
18%, cognitive score had 8%, activities of 
daily living score had 1%, BMI had 14%, 
and CES-D had 0.2%. Analyses were 
performed using SPSS Statistics (version 
20; SPSS, Chicago, IL, USA).
RESULTS
had a lower level of education, and were 
more likely to have clinically relevant 
depressive symptoms. The main cause 
for grief was death of a partner (36% of 
those with normal grief and 56% of those 
with complicated grief), or a child (10% of 
those with normal grief and 22% of those 
with complicated grief).
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Table 1. Baseline Characteristics of Study Participants 2002–2005 (N = 5,421)
Group comparisons were performed with χ2 (categorical variables) or t-test (continuous variables) for independent samples. 
aComparison of nongrieving participants with grieving participants (p < 0.05). bComparison of nongrieving participants with 
complicated-grief participants (p < 0.05). cComparison of grief participants with complicated-grief participants (p < 0.05).
Characteristics
Age, years (SD)
Women (%)
Educationa.b
Primary (%)
Intermediate (%)
High (%)
Cognitive functioning, score (SD)
Depressive symptoms, score (SD)
Clinically relevant depressive symptoms (%)
Who died?
Partner (%)
Child (%)
Parent (%)
Brother/sister (%)
Others (%)
Activities of daily living, score (SD)
Body mass index (kg/m2), (SD)
Sleep duration (hours), (SD)
Sleep quality, score (SD)
72.4
55
19
67
14
27.41
5.42
4
–
–
–
–
–
0.51
27.56
6.91
3.37
(7.7)
(2.58)
(6.67)
(0.57)
(4.03)
(1.30)
(2.91)
73.4
73a
22
66
12
27.39
8.62
8a
36
10
12
17
25
0.59
27.67
6.69
4.28
(8.1)a
(2.52)a
(8.49)a
(0.57)a
(4.34)
(1.36)a
(3.20)a
74.7
72b
30
63
7
26.99
14.12
25b,c
56
22
6
7
9
0.66
27.75
6.44
5.08
(7.5)b
(3.04)b,c
(11.35)b,c
(0.60)b
(4.38)
(1.50)b,c
(3.67)b,c
Nongrievers
N = 4,378 (80%)
Normal grievers
N = 795 (15%)
Complicated grievers
N = 248 (5%)
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Table 2 shows the cross-sectional 
associations of grief with sleep duration 
and sleep quality. In the age-and-
gender adjusted analysis, we found a 
consistent association pattern of grief 
and complicated grief with sleep duration 
as well as with sleep quality. Further, 
adjustment for education level, activities 
of daily living, cognitive functioning, and 
body mass index did not change these 
associations. However, the association 
between grief and sleep indicators was 
explained by depressive symptoms 
(model 3).
In Table 3 we present the prospective 
association of grief with sleep duration 
and sleep quality (both assessed at follow 
up exam after 6.33 years on average (SD 
= 0.42)). We did not find an association 
of grief or complicated grief with changes 
in sleep duration or sleep quality, either in 
the age-and-gender adjusted or in the fully 
adjusted analyses. Next, we performed 
a series of sensitivity analyses. First, we 
excluded persons with major depression 
from our study population and reran the 
analysis; our result remained essentially 
unchanged. Then we limited the cases to 
those who experienced the bereavement 
leading to complicated grief in the last 
2 years prior to baseline assessment 
(Supplement B). Our result showed no 
association between more recent lost event 
and sleep parameters in the longitudinal 
analysis. Also, to test whether the 
differences between cross-sectional and 
longitudinal analysis reflect a selection 
effect, we reran the cross-sectional 
analysis in participants who attended the 
follow-up assessment. Results remained 
essentially unchanged; the cross-sectional 
associations of complicated grief with 
sleep duration and sleep quality were 
similar to our original cross-sectional 
findings (data shown in Supplement 
C). Also, the results did not change 
when we reran the analysis calculating 
the PSQI score without including the 
sleep duration component (Supplement 
D). Next, in the longitudinal analysis, 
exclusion of subjects who had poor sleep 
quality at baseline did not change the 
results (Supplement E). Furthermore, 
we did not find any difference in sleep 
duration or sleep quality between grievers 
and complicated grievers in both cross-
sectional and longitudinal analysis (data 
not shown). Last, we did not find an 
association between baseline grief status 
and depressive symptoms at follow-up 
(grievers: β = –0.22, 95% CI: –1.51—1.07, 
p = 0.74; complicated grievers: β = 1.00, 
95% CI: –1.30—3.31, p = 0.39).
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In this large population-based study of 
middle-aged and elderly persons, we 
investigated whether persons with grief 
or complicated grief had a different 
sleep duration and sleep quality than 
participants without grief. Our cross-
sectional findings showed that normal 
and complicated grief were associated 
with shorter sleep and lower sleep quality. 
These associations were mainly explained 
by the presence of depressive symptoms. 
No further changes in sleep duration and 
sleep quality between the groups were 
observed after an average follow-up of 
more than 6 years. Complicated grief can 
be regarded as a bereavement situation 
for which sleep duration is likely to be 
affected (Monk, Germain, et al., 2008). 
A cross-sectional study of duration of 
sleep among unselected grievers, that is, 
most probably including persons with 
complicated grief, has been reported 
previously (Monk, Germain, et al., 2008). 
The authors conducted a laboratory 
study of sleep and circadian rhythm in 
38 spousal bereaved seniors (≥ 60 years) 
observed 4 or more months after their 
loss event. On average, the bereaved 
seniors achieved only about 6 hr of sleep. 
In a large Japanese population-based 
prevalence study of 1,871 participants 
conducted by Doi, Minowa, Okawa, and 
Uchiyama (2000), the authors showed 
that being widowed or without a partner 
was associated with lower sleep quality.
There is evidence suggesting that 
behavioral changes associated with 
grief such as decreased activity levels 
or overall changes in social rhythm 
stability could lead bereavement to sleep 
disturbances. After the loss of a loved one, 
there are profound changes in lifestyle, 
often accompanied by reductions in 
financial security, perceived personal 
safety, and freedom of action (Monk, 
Germain, et al., 2008), all of which are 
likely to lead to sleep disruption. Also, 
the loss of a loved one is associated 
with psychological problems such as 
rumination or anxiety, which are shown 
to impair sleep (Carney, Edinger, Meyer, 
Lindman, & Istre, 2006; K. Shear et al., 
2007). Sleep disturbances are particularly 
prevalent in depressed bereaved persons; 
even bereaved persons who fail to meet 
a formal diagnosis of depression have 
measurable sleep impairment (Reynolds 
et al., 1992). Indeed, our cross- sectional 
analysis showed that the association 
between grief and complicated grief with 
sleep indicators was largely explained by 
depressive symptoms. 
DISCUSSION
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However, we ran multivariable linear 
regression models to see if baseline 
grief status was prospectively associated 
with CES-D at follow-up and found 
no association, providing support that 
depressive symptoms are not a mediator 
in the association between grief and sleep 
parameters. Further, reversed causality 
should be taken into account. Since 
relatively few studies have yet examined 
sleep difficulties as a risk factor for post-
loss psychopathology, we cannot rule 
out that existing sleep problems make 
individuals vulnerable to more severe 
or prolonged grief or complicated grief. 
Indeed, as Boelen and Lancee (2013) 
pointed out, poor sleep quality is a known 
risk factor for many different forms of a 
psychopathology, including depression 
and PTSD.
We did not find a prospective association 
between grief and sleep parameters. 
Different explanations for these null 
findings are possible: First, the lack of 
findings can reflect the insufficient power 
to detect an association. Although fewer 
participants could be included in the 
longitudinal analyses, sufficient power to 
detect any effect similar to that observed 
in the cross-sectional analyses remained. 
Thus, these findings suggest that there was 
no further change in sleep duration and 
sleep quality once a person had reported 
bereavement at our baseline assessment. 
We carefully infer that the results could be 
explained with mechanisms of adaptive 
coping (S. S. Rubin, 1999; Stroebe & 
Schut, 1999) developed by the grieving 
participants during prolonged exposure 
to grief. 
Possibly, persons grieving reached a 
“stable state,” that is, with no further 
change of sleep quality, when participating 
in the follow-up assessment on average 6 
years after the event. Sleep quality might 
have been affected before the occurrence 
of complicated grief. 
Due to the lack of prebereavement sleep 
assessment, it is not possible to evaluate the 
directional effects in the cross-sectional 
analysis, that is, whether bereavement 
triggered the decline of sleep duration 
and quality or whether sleep impairment 
preceded the grief reaction. However, our 
sensitivity analysis in which we excluded 
participants with poor sleep quality 
provides no evidence for reverse causality. 
Also, grief was assessed only at baseline. 
Consequently, we cannot account for the 
change in grief status, whether the feelings 
of grief remitted, persisted, or worsened.
However, the majority of clinical diseases 
and conditions are characterized by 
a progression of symptoms and their 
consequences; against this background, 
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In community-dwelling middle-aged and 
older adults, persons with normal and 
complicated grief had both a shorter sleep 
duration and a lower sleep quality, mainly 
explained by depressive symptoms. 
However, prospective analyses showed 
that sleep quality and sleep duration 
do not decline further in persons with 
normal grief and complicated grief.
we had hypothesized a continuous decline 
of sleep problems, having in mind that 
sleep duration and quality among persons 
with complicated grief is of potential 
value for prognosis of grieving persons 
and potentially even of relevance for 
therapeutic interventions that rely on 
the cognitive behavioral interventions 
focused on sleep difficulties as discussed 
by Boelen and Lancee (2013). It suggests 
that the impact of grief on this important 
aspect of well-being is not accumulating 
over time and can potentially be overcome.
To the best of our knowledge, other 
longitudinal studies have not been 
performed previously in the general 
population. Also, our study is 
characterized by a long follow-up period 
and a large sample size. Furthermore, 
a middle-aged and elderly sample was 
used, which is the main vulnerable 
population for complicated grievers, as 
late-life loss of a loved one is among the 
most common life events. However, some 
limitations of the current study should be 
mentioned. First, in a population-based 
study, it is not feasible to ascertain grief 
and sleep directly after a loss event. Most 
important, complicated grief cannot be 
diagnosed if the event occurred less than 
6 months before. Therefore, we performed 
sensitivity analyses restricting the study 
population to those who experienced the 
bereavement more recently (in the last 
2 years before the baseline assessment). 
Second, we miss information on whether 
these persons are still suffering from 
complicated grief or MDD at follow-up. 
Further studies should be performed 
including this kind of prospective 
reassessment.
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ABSTRACT
Objective: Few studies have focused on the 
effect of complicated grief—unresolved 
and prolonged grief—on the neuro-
endocrine systems. The present study 
examined the association of complicated 
grief and normal grief with the diurnal 
cortisol patterns in a large population-
based study.
Methods: This study was set in the 
Rotterdam Study and comprised 2084 
persons aged older than 55 years (mean 
[SD] age, 64.9 [5.5] years). Participants 
were assessed with the Complicated 
Grief Inventory and classified into no 
grief (n = 1922), normal grief (n = 131), 
or complicated grief (n = 31) if they 
experienced the loss in the past 2 years. 
Saliva samples were collected to measure 
cortisol levels. Morning cortisol and 
summary measures (area under the curve 
and the slope) were studied to account for 
the diurnal pattern of cortisol. Persons 
with depressive disorders were excluded, 
and analyses were additionally adjusted 
for depressive symptoms.
Results: Compared to normal grievers, 
participants with complicated grief 
showed lower levels of morning cortisol 
(11.26 vs 15.51 nmol/L; difference, −4.24; 
95% confidence interval [CI] = −7.87 to 
−0.62; p = .022), and lower levels of overall 
diurnal cortisol (6.89 vs 8.98 nmol/L; 
difference, −2.09; 95% CI = −3.81 to −0.37; 
p = .017). No difference was observed in 
slope between both groups. Participants 
with complicated grief also showed 
lower levels of morning cortisol than the 
nongrievers (11.26 vs 14.71; difference, 
−3.46; 95% CI = −6.78 to −0.13; p = .042). 
In contrast, cortisol secretion patterns did 
not differ between persons with normal 
grief and nongrieving controls.
Conclusions: Participants with 
complicated grief showed low levels of 
morning cortisol and low overall diurnal 
cortisol levels characteristic for a chronic 
stress reaction.
Key words: grief, complicated grief, 
complicated grief, cortisol, hypothalamic-
pituitary-adrenocortical axis, population 
based, coping.
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INTRODUCTION
Bereavement is defined as having 
experienced a significant loss (1). Its most 
common reaction is grief (2).
Grief knows many different 
manifestations and courses, but 
grief itself is not a mental disorder. 
However, approximately 9% to 20% 
of the population experiencing 
bereavement show symptoms of an 
unresolved and prolonged grief termed 
“complicated grief ” (3). Complicated 
grief has been referred to as “traumatic 
grief,” “complicated grief disorder,” 
and “prolonged grief ” and is distinctly 
different from “depression accounted 
for by bereavement,” as mentioned in 
the Diagnostic and Statistical Manual 
of Mental Disorders, Fourth Edition 
(DSM-IV) (4). Recently, complicated 
grief has been included within the section 
“conditions for further study” in DSM-V 
section as persistent complex bereavement 
disorder (5).
Complicated grief includes a set of 
symptoms such as persistent intense 
yearning for the deceased, intense feelings 
of loneliness, feelings of disbelief or that 
life is empty, being emotionally numb or 
troubling accepting the death, bitterness, 
intrusion and rumination of thoughts or 
images of the dead person, and hearing or 
seeing the deceased person, lasting for at 
least 6 months (4,6,7).
The etiology of complicated grief is not 
well established, although psychosocial 
risk factors have been described, such 
as an unexpected death or suicide of the 
deceased (8,9), lack of social support, or 
fewer preloss coping resources (lower 
selfperceived coping efficacy; lower 
religiosity) (10,11), excessive dependence 
on the deceased (12), and pessimistic 
temperament (13).
The death of a loved one can be one 
of the most stressful events a person 
must endure (14). Under conditions 
of stress, the hypothalamic-pituitary-
adrenocortical (HPA) axis is stimulated, 
and it activates the secretion of cortisol 
into the bloodstream. Acute psychosocial 
ACTH = adrenocorticotropic hormone, AUC = area under the curve, BMI = body mass 
index, CES-D = Centre for Epidemiologic Studies of Depression, CG = complicated 
grief, HPA = hypothalamic-pituitary-adrenocortical axis, ICG = inventory of 
complicated grief, MMSE = mini mental score, RS = Rotterdam Study, SD = standard 
deviation.
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stress is typically accompanied by 
increased secretion of cortisol, as an 
adaptation to the stressor, and then 
decreases to normal levels; but it is the 
chronic dysregulation of cortisol that is 
implicated in a host of psychological and 
physical health conditions (15). A recent 
meta-analysis found that compared to 
nonstressed controls, chronically stressed 
persons more often had a dysregulated 
pattern of cortisol secretion. This pattern 
was characterized by lower morning 
secretion and higher secretion across the 
rest of the day, yielding a flattened diurnal 
pattern (16). In depressed persons, higher 
levels of cortisol secretion have been 
reported widely, although in chronic 
depression and in community-dwelling 
depressed persons, low levels of morning 
cortisol have also been observed (17). 
Likewise, low cortisol levels are reported 
in studies of chronic fatigue syndrome 
(18–23) and in studies of post-traumatic 
stress disorder and after traumatic events 
(24–26).
Previous studies of grief and cortisol 
showed that the loss of a loved one is 
associated with more dysregulated cortisol 
patterns and an increased mortality risk of 
the bereaved person (14,16). Richardson et 
al. studied bereaved spouses and the effect 
of a prolonged forewarning of the death 
(i.e., knowing at least 1 month before the 
death that the person is going to die in the 
coming months). The group of bereaved 
persons who reported a forewarning of 
death showed higher cortisol levels at 6 
month than those bereaved who did not 
experience prolonged forewarning (27). 
Few studies have investigated the 
relationship between cortisol and 
complicated grief. One study compared 
12 women with complicated grief to 12 
women with normal grief, showing a 
flatter slope across the day in those with 
complicated grief (28). Another study 
compared 56 depressed adults, divided 
into three groups of nonbereaved, 
bereaved without signs of complicated 
grief, and bereaved with complicated grief 
symptoms. Interestingly, the depressed 
bereaved persons had lower levels of 
log-cortisol at wake and flatter diurnal 
slopes compared with the depressed 
nonbereaved independent of complicated 
grief symptoms (29). Against this 
background and given the phenotypical 
correlation of complicated grief and 
chronic depression and post-traumatic 
stress disorder (PTSD), both of which 
have been related to lower cortisol values, 
we examined the association between 
complicated grief and cortisol measures.
We focused on persons with duration of 
complicated grief up to 2 and 5 years after 
the loss (30). The aim of our study was to 
examine the association of the morning 
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cortisol and summary cortisol measures 
with grief and complicated grief. We 
tested two hypotheses. First, persons 
with complicated grief symptoms have 
a lower diurnal cortisol secretion than 
those without grief or with normal grief. 
Second, persons with normal grief have a 
similar cortisol secretion pattern as those 
without grief.
METHODS
Study Participants
This study was set in the Rotterdam 
Study, a large prospective population-
based cohort designed to examine the 
occurrence and risk factors of chronic 
diseases. The study has been described 
in detail elsewhere (31). In 1990, all 
residents in a district of Rotterdam who 
were aged 55 years and older were invited 
to participate. Every 4 years, participants 
undergo an extensive home interview 
and physical examination at a research 
center. The Medical Ethics Committee 
of the Erasmus University of Rotterdam 
approved the study, and informed consent 
was obtained from all participants. The 
current study is based on the fourth 
examination of the original cohort 
members (n = 7983). The examination 
was performed in 2002–2004 with 3550 
participants (74% response rate), and it 
assessed complicated grief and salivary 
cortisol levels.
For the present study, we excluded 
participants with incomplete com-
plicated grief inventory (n = 187), those 
using corticosteroids (n = 78), without 
salivary cortisol measures (n = 840), and 
persons with complicated grief less than 
6 months after loss (n = 18) or grieving 
more than 2 years (n = 313). This resulted 
in 2084 elderly persons aged older than 55 
years (M [SD] age, 64.9 [5.5] years; 55% 
women) for the analyses of 2 years after 
loss. Another 130 grieving persons were 
additionally included in the analyses of all 
persons that experienced grief in the past 
5 years.
Assessment of Complicated Grief
All participants were asked if they were 
currently grieving (3).If the answer was 
positive, we asked whom they were 
grieving over (spouse, partner, child, 
parent, sibling, other family member, close 
friend, other, several people, including or 
excluding spouse) and the time elapsed 
since the death. The participants, who 
answered the first question affirmatively, 
were assessed for complicated grief with 
the Dutch version of the Inventory of 
Complicated Grief (ICG).
In the present study, we used two different 
cut-offs to limit the time since loss. The 
primary analyses used a 2-year cut-off 
since bereavement and included all 
participants with grief (≤2 years) and 
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complicated grief (≥6 months to 2 years). 
The second and contrasting analyses 
used a 5-year cut-off since bereavement, 
and included all participants with grief 
and complicated grief up to 5 years after 
bereavement. However, at least 6-month 
duration of symptoms was required in 
accordance with recommendations for 
diagnostic criteria and to exclude acute 
stress reaction (32). The choice of the 
2-year postloss cut-off was made to 
study the association with more recent 
complicated grief in line with a previous 
study (3) and the cut-off has also been 
used in previous analyses of the present 
cohort (33). 
However, we also present analyses 
including all persons (N = 292) with grief 
or complicated grief up to 5 years after loss. 
Complicated grief was diagnosed with 
the Dutch version of the ICG. Questions 
represent symptoms of complicated 
grief based on the most recent proposed 
criteria. The ICG is considered the 
criterion standard for measurement of 
complicated grief in older adults because 
it has high internal consistency, good 
convergent and criterion validity (34). 
The inventory represents a single un-
derlying construct of complicated grief. 
As described before (3), 17 questions 
were asked, and responses were provided 
on a five-point scale to reflect an increase 
in severity (0, never; 1, seldom; 2, 
sometimes; 3, often; and 4, always). In 
the current setting, one item, “I feel bitter 
over this person’s death,” was removed 
from the original inventory, as a pilot 
study revealed that this sentiment had a 
very similar meaning within the Dutch 
language as the included item: “I feel anger 
over this person’s death.” Two further 
items (relating to seeing and hearing 
the deceased) were combined into one 
due to their similarity, and a pilot study 
indicating these symptoms were low in 
frequency and too often overlapped (“I 
hear the voice of, or see, the person who 
died”).
A summary score for the ICG was 
calculated by totaling each individual 
item score (responses from 0, never, to 
4, always) across the 17 items providing 
a potential score range of 0 to 68. 
Participants with a score of less than 22 
were considered as participants with grief 
symptoms in line with previous studies 
(3).
We defined complicated grief based on 
the severity of symptoms and did not 
define severity by duration of symptoms. 
Participants with a score of less than 22 
were considered participants with grief 
symptoms in line with previous studies 
(3). Participants with a score of 22 or 
greater and with symptoms lasting after 
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for at least 6 months were considered to 
have complicated grief. This cut-off was 
based on the cut-off in the original version 
of the ICG (original cut-off of 25 from 
19 items). We classified participants into 
three groups; no grief (control group), 
persons with normal grief (experiencing 
non-complicated grief as shown by an ICG 
score <22) and those with complicated 
grief (ICG score ≥22). The non-grieving 
control group included persons who had 
experienced bereavement in the past but 
were not grieving at the time of interview. 
Likewise, persons mourning over 
someone with severe disease, but who 
were still alive or a pet, were included in 
the control group.
Salivary Cortisol Protocol
Saliva samples were collected on 
awakening (T1), 30 minutes after 
awakening (T2), at 5:00 PM (T3), 
and at bedtime (T4). Salivary cortisol 
concentrations were measured using 
a commercial immunoassay with 
chemiluminescence detection (IBL 
Hamburg, Hamburg, Germany). Intra-
assay and inter-assay coefficients 
of variation were less than 6% and 9%, 
respectively. The lower limit of detection 
was 0.4 nmol/L. Data were screened 
for quality of cortisol measurements. 
For each time point, cortisol values that 
were above the 98th percentile in the 
original cortisol data set were excluded 
from the final data set to normalize the 
distribution of cortisol measurements 
and to exclude misclassification due 
to possible measurement errors. After 
this exclusion, cortisol levels followed 
a normal distribution (35). The individual 
measures of cortisol were combined 
in summary measures to provide valid 
information about the diurnal pattern of 
cortisol. We calculated the area under the 
curve with respect to the ground (AUCg) 
and the slope. The AUCg summarizes overall 
diurnal cortisol exposure, and was calculated 
as the local AUC from the individual cortisol 
measures on the Y-axis and the time between 
cortisol measures on the X-axis. It takes 
into account both sensitivity (the difference 
between the single measurements from each 
other) and intensity (the distance of these 
measures from ground) (36,37). In order 
not to include the effect of the morning rise 
as part of the AUC, we did not include T2 
in the AUC calculation. Diurnal decline was 
assessed by a slope, which was calculated 
by fitting a linear regression line for each 
participant, which predicted the cortisol 
values from time since awakening. A greater 
decline in the daytime cortisol means that 
the slope of the regression line is steeper, 
whereas a lesser decline means that the 
slope is flatter.
Assessment of Other Variables
Age, sex, education level, smoking status, 
body mass index, cognitive status, major 
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depression, depressive symptoms, and 
anxiety symptoms were evaluated as 
potential confounders based on previous 
publication (38–41). The time between 
subsequent cortisol measurements within 
the same day was used as a covariate in 
the analyses of the AUC and the slope. 
Information was collected in home 
interviews and physical examination at 
baseline (42).
Level of education was assessed during 
home interview and was classified 
into those with primary education 
only, intermediate education, and 
high education (university studies). 
Participants were asked about their 
smoking status (never, current, and 
former). Current smokers were asked 
how many cigarettes they smoked daily 
and how long they had been smoking. 
Former smokers were asked about their 
smoking history (39). Height and weight 
were measured in participants without 
shoes and heavy clothes, and body mass 
index was calculated as kilogram per 
square meter (kg/m2) and used as a 
continuous variable (43). Cognitive status 
was evaluated with the Mini Mental 
Status Examination (44) and used as a 
continuous variable. Depressive symptoms 
were assessed with a validated Dutch 
version of the Centre for Epidemiologic 
Studies Depression (CES-D) scale (range, 
0–60) to obtain a continuous measure 
of depressive symptoms (45,46). All 
participants with clinically relevant 
depressive symptoms (i.e., those with 
a scores of 16 or greater on the Centre 
for Epidemiologic Studies Depression), 
were interviewed using the Present State 
Examination, a semistructured psychiatric 
interview included in the Schedules for 
Clinical Assessment in Neuropsychiatry. 
All interviews were conducted by two 
experienced clinicians. Major depression 
was classified according to the DSM-IV 
(47).
Anxiety disorders were diagnosed with an 
adapted version of the Munich version of 
the Composite International Diagnostic 
Interview to assess the following anxiety 
disorders: generalized anxiety disorder, 
panic disorder with or without history 
of agoraphobia, agoraphobia, social 
phobia, and specific phobia. Obsessive-
compulsive disorder and PTSD, which are 
part of the anxiety disorders in the DSM-
IV, were not assessed. The Composite 
International Diagnostic Interview was 
specifically designed to obtain DSM-IV 
diagnoses of mental disorders (48).
Assessment of Exclusion Criteria
Participants using corticosteroid were 
excluded. Pharmacy records were used to 
collect data on systemic corticosteroid use 
(39).
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Statistical Analysis
Information on demographic 
characteristics was compared among the 
groups using a χ2 test for categorical data 
and an analysis of variance for continuous 
variables. 
We investigated the association of 
complicated grief with cortisol, the single 
(T1 morning cortisol) and the summary 
measures (AUC and slope). The primary 
analyses included as cases only persons 
who grieved after a loss up to 2 years ago, 
as this cut-off was used previously (30). 
The second analysis included persons 
who were grieving after bereavement 5 
or less years ago. We compared cortisol 
measures of the reference population 
to participants with normal grief and 
to those with complicated grief using 
analysis of covariance.
The analyses were adjusted for age and 
sex, level of education, smoking status, 
body mass index, Mini Mental State 
Examination score, current depressive 
symptoms, and time between cortisol 
measures (for TI, T2, T3, and T4). 
Covariates were imputed using the 
expectation-maximization algorithm. 
All covariates had less than 3% missing 
values. Missing values were imputed 
based on the entire baseline population (n 
= 3550).
Although the ICG is designed as a 
screening measure and not to assess 
severity of grief, we performed continuous 
analyses in persons grieving using the 
scores on the ICG to test whether there is 
a dose-response relationship between the 
grief symptoms score and cortisol levels 
independently of the predefined cut-off.
RESULTS
The study population comprised 1922 
persons with no grief, 131 with normal 
grief, and 31 with complicated grief 
of maximal 2 years duration. In the 
sensitivity of persons with up to 5 years 
after loss, 210 persons with normal grief, 
and 82 persons with complicated grief 
were included.
Table 1 presents the characteristics of 
the study population. The sample was 
composed of 55% women, and the M 
(SD) age of the participants was 64.9 (5.5) 
years. Participants with complicated grief 
were more often women, and they were 
older than persons without grief. 
The main cause of grieving in those with 
complicated grief was death of the partner 
(61%), and in those with normal grief, it 
was death of a partner (29%) or a sibling 
(22%). Participants with complicated 
grief had more clinical relevant depressive 
symptoms (18.4%), major depression 
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(13.2%), and anxiety symptoms (18.4%) 
than persons without grief or those with 
normal grief.
Table 2 shows the cortisol saliva measures 
(morning cortisol, AUC, and slope) of 
the participants with no grief, normal 
grievers, and complicated grievers who 
experienced the loss in the past 2 years.
 
Participants with complicated grief had 
lower levels of morning cortisol than 
normal grievers (11.26 vs 15.51 nmol/L; 
difference, −4.24; 95% CI = −7.87 to −0.62; 
p = .02). Persons with complicated grief 
also had lower overall diurnal cortisol 
levels (AUCg) (6.89 vs 8.98 nmol/L; 
difference, −2.09; 95% CI = −3.81 to −0.37; 
p = .017). The difference in the slope of 
cortisol observed between both groups 
did not reach significance. Consistently, 
participants with complicated grief were 
found to have lower levels of morning 
cortisol than nongrievers (11.26 vs 14.71; 
difference, −3.46; 95% CI = −6.78 to 
−0.13; p = .042). Neither the difference in 
overall cortisol levels nor the difference 
in cortisol slope reached statistical 
significance, although the effect estimates 
suggest a meaningful difference.
The table does not show the formal contrast 
between those with grief and without grief 
in the table; none of the group means 
between those with normal grief and those 
without grief reached significance (data not 
shown). However, the table clearly shows 
that the means of all cortisol measures are 
very similar in these two groups.
Table 1. Baseline Characteristics of the Study Sample, N = 2084
SD,standard deviation; CES-D, Center of Epidemiological Studies-Depression scale; BMI, body mass index; MMSE,Mini 
Mental State Examination.
Data are presented as n (%) unless otherwise indicated.
Participants with grief (ICG < 22) from 0 month to 2 years aer loss and participants with complicated grief (ICG ≥ 22) from 6 
months to 2 years aer loss were included. Participants using corticoids were excluded. Chi-square test and analysis of variance 
were performed.
Characteristic
Sex, women
Continuous variables, M (SD)
Age, M (SD), years,
CES-D score, M (SD)
BMI, M (SD), kg/m2
MMSE score, M (SD)
Education
Primary
Intermediate
High school
Smoking status
Never smoked
Current smoker
Former smoker
Anxiety symptoms
Who died?
Partner
Child
Parent
Brother/sister
Others (another family member, good friend, several)
No Grief n = 1922
 
1056 (55)
63.5 (5.6)
5.1 (6.1)
27.4 (3.9)
27.5 (2.2)
 
515 (27)
1380 (72)
27 (1.4)
 
603 (31)
234 (12)
1085 (57)
144 (7.5)
 
—
—
—
—
—
Grief n = 131
 
89 (68)
 
65.3 (6.3)
7.6 (6.6)
27.2 (4.2)
27.4 (2.5)
 
37 (28)
90 (69)
4 (3.1)
 
49 (37)
12 (9)
70 (53)
12 (9)
 
38 (29)
7 (5)
4 (3)
29 (22)
52 (40)
Complicated 
Grief n = 31
 
21 (68)
 
65.9 (4.7)
13.8 (9.8)
26.1 (2.4)
27.6 (1.9)
 
10 (32)
21 (68)
0 (0)
 
14 (45)
3 (10)
14 (45)
6 (19)
 
19 (61)
1 (3)
0 (0)
4 (13)
7 (23)
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Table 3 presents the results of our 
sensitivity analyses. The groups now 
include all persons that experienced grief 
or complicated grief up to 5 years ago 
(those experiencing grief 2 to 5 years were 
added in these analyses). No differences 
between the participants with grief, 
complicated grief, and those without 
any grief in the cortisol morning levels 
or the two sum measures were observed 
anymore, whatever the reference and 
comparison group. Consequently, we 
tested if the cortisol measures of persons 
with complicated grief differed depending 
on time since bereavement. To this aim, we 
defined exclusive groups of complicated 
grievers less than 2 years and between 2 
and 5 years since bereavement. Both the 
AUCg (CG 2 years, 6.84 nmol/L; CG >2–5 
years, 9.23 nmol/L; difference, −2.393; CI 
= −4.21 to −0.57; F-statistic, 3.33; p = .01) 
and the morning cortisol levels (CG 2 
years, 11.85 nmol/L; CG >2–5 years, 16.44 
nmol/L; difference, −4.58; CI = −8.46 to 
−0.70; F-statistic, 2.69; p = .021) differed in 
persons with complicated grief depending 
on the time since bereavement.
The continuous analyses in persons with 
grief experienced in the past 5 years 
showed that higher scores on the ICG 
were associated with lower morning 
cortisol (B = −0.270; 95% CI = 11.94 to 
−0.72; p = .027).
DISCUSSION
In this population-based study, we 
studied whether diurnal cortisol secretion 
of persons with complicated grief or 
persons with normal grief differed from 
those not experiencing grief in the past 
2 years. As hypothesized, the present 
study demonstrated that participants with 
complicated grief 2 years after loss showed 
lower level of morning cortisol and lower 
overall diurnal cortisol exposure than the 
participants with grief or without grief. 
In contrast, persons with grief showed 
similar cortisol secretion patterns as those 
without grief.
Cortisol is frequently referred to as 
the “stress hormone.” Stressful life 
circumstances stimulate hypothalamic-
pituitary-adrenocortical (HPA) axis, 
activating a hormonal response system 
that results in increased blood levels of 
cortisol (45). However, hypocortisolism 
has been observed in patients, who 
developed PTSD (21,46,47) and has also 
been reported in patients with bodily 
disorders, such as burnout with physical 
complaints, chronic fatigue syndrome, 
fibromyalgia, and chronic pelvic pain 
(16,17,20,22,48,49). Similar findings have 
been reported for healthy individuals 
living under conditions of chronic stress, 
chronic depression, as well as for patients 
with rheumatoid arthritis and asthma 
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(13,14,49). Our observations in persons 
with complicated grief extend these latter 
findings. Whereas a previous study of 
complicated grief and diurnal cortisol 
showed that those with complicated grief 
have a flatter slope across the day (25), 
morning cortisol or AUC has not been 
examined in persons with complicated 
grief.
Several mechanisms may be involved 
in the development of hypocortisolism. 
First, reduced biosynthesis of cortisol as 
part of an adaptive down-regulation has 
been postulated in persons experiencing 
severe trauma (48,50). Second, increased 
sensitivity of the HPA axis for negative 
feedback (51,52) and corticotropin-
releasing factor hyper secretion from the 
hypothalamus are discussed, as these can 
result in reduced adrenocorticotropic 
hormone and lower cortisol levels (49). 
Third, a very different but not necessarily 
exclusive mechanism is suggested by prior 
work from our group. We have previously 
shown that persons with complicated grief 
are characterized by more brain atrophy 
than persons with grief. Neuronal loss may 
disrupt the microstructural integrity of 
the fascicles connecting pre-frontal cortex 
with the subcortical areas (amygdala 
and hip-pocampus) (30,53), which are 
involved in the inhibitory regulation of 
the HPA axis (52,54,55). Morphological 
brain changes have also been described 
in patients with PTSD, such as a reduced 
volume of the hippocampus, which is 
predominantly involved in the inhibitory 
regulation of the HPA axis (52,54,55).
Our data, however, suggest also that any 
such mechanisms behind hypocortisolism 
may sometimes be reversible. In the 
present study, no effect of grief or 
complicated grief on cortisol secretion 
patterns was observed, if persons with 
longer periods since the loss were 
included. This suggests that with longer 
follow-up time, the association between 
grief and cortisol may attenuate. We can 
only carefully speculate about coping in 
this interval. Participants with more than 
2 years after loss may have adapted to the 
loss and the resulting changes, instead of 
avoiding the loss. Several studies proposed 
that complicated grief reactions only 
persist when people engage in avoidance 
behaviors trying to impede habituation to 
painful memories and interfering with the 
integration of the loss (56–58).
In our study, we found no differences in 
diurnal secretion cortisol and persons 
with normal grief and the controls. 
These findings were not unexpected if 
one views grief as a normal life event, 
unrelated to preexisting vulnerabilities. 
Effects on the HPA axis may be visible 
after several months or even years only 
if a person develops complicated grief 
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or has risk factors for complicated grief 
such as a dependent relationship with the 
dead person, unexpected dead, lack of 
social support, and the loss of someone 
who was ambivalently loved (30). Our 
results suggest that persons with normal 
grief may have a healthier coping style. 
Alternatively, they experience less of those 
grief-related feelings and behaviors, which 
tend to dominate severe bereavement and 
may affect the HPA axis (59).
Strengths of our study include the sample 
size, the population-based setting, and the 
multiple daily cortisol measurements. A 
large control group of nongrieving persons 
was provided the reference for participants 
with normal grief or complicated grief. 
In addition, we controlled for clinically 
relevant depressive symptoms and major 
depression.
Some limitations of the current study 
should also be mentioned. First, it is not 
possible to evaluate if these associations 
were causal due to the cross-sectional 
design of the study. In particular, we do 
not have cortisol assessments before grief, 
nor in the next examination round. Thus, 
we cannot rule out that existing alterations 
in HPA axis activity made some persons 
more susceptible to develop complicated 
grief. Second, not all the participants with 
ICG participated in the saliva sampling. 
Third, selection effects may have led to the 
inclusion of more grievers with healthy 
coping style in those persons whose loss 
events occurred long ago. This would 
have diluted the effects. Fourth, it is not 
possible to account for complicated grief 
with PTSD because in the Rotterdam 
Study, this was not assessed. Fifth, we 
do not have longitudinal data to study 
the factors that might be involved on the 
reversibility of the cortisol secretion. In 
addition, we cannot rule out that existing 
alterations in HPA axis activity made 
some persons more susceptible to develop 
complicated grief.
The importance of our study is that 
cortisol, which is involved in cognitive 
functions such as memory performance 
and executive function and regulates the 
inflammatory responses, is altered in 
persons experiencing complicated grief 
(12,48,49,60). This implies that persons 
with complicated grief may be more 
vulnerable to develop cognitive problems 
(30), depression, and medical conditions 
than persons with normal grief. Follow-
up studies are needed, however, to 
demonstrate the clinical consequences of 
our observations.
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The present study included 1047 elderly 
participants. At baseline, brain magnetic 
resonance imaging (MRI) was performed 
to detect infarcts and white matter 
lesions; further, depressive disorders were 
Abstract
assessed. Participants were followed up 
during 3.6 years to determine incident 
and recurrent depression. We found an 
increased risk of recurrent depression 
associated with silent brain infarcts.
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1. Introduction
A relationship between cerebrovascular 
disease and depression in the elderly has 
been established (Baldwin and O’Brien, 
2002). However, it remains unclear to what 
extent depression is a direct consequence 
of vascular damage or a psychological 
reaction to physical disability caused by 
stroke.
Studies investigating the relation between 
cerebral white matter lesions (WMLs) 
and depression provided evidence that 
subclinical cerebrovascular disease is 
associated with depression (Grool et al., 
2011), although not consistently (Ikram, 
2010). Also, silent brain infarcts (SBIs) 
detected by magnetic resonance imaging 
(MRI) in the absence of clinical stroke are 
frequent in depressed patients (Vermeer, 
2007).
The association between SBIs and 
depression in the elderly has not been 
studied longitudinally; only the prognosis 
of prevalent depression in patients with 
silent brain infarct has been examined 
(Yamashita et al., 2010). Furthermore, 
previous studies were based on small, 
clinical samples. Previous research on the 
relationship between SBI and the poor 
prognosis of patients with depression 
or lack of response to antidepressant 
treatment prompted us to investigate 
the possible relationship between SBI and 
recurrent depression (Yamashita et al., 2010, 
2001).
Therefore, we aimed to assess whether SBIs 
and WMLs in community-dwelling elderly 
increase the risk of incident and recurrent 
depression.
2. Methods
2.1. Setting
The current study is embedded in the 
Rotterdam Scan Study in the elderly, a large 
population-based neuroimaging study. We 
randomly selected participants from two 
large ongoing population-based studies, 
the Zoetermeer Study and the Rotterdam 
Study (Vermeer et al., 2003). After 2000, 
only the Rotterdam Study subcohort was 
followed. Together with non-participation 
and death of respondents, this substantial 
reduction in participants, precluded longer 
follow-up analysis. The study was approved 
by the medical ethics committee of Erasmus 
Medical Center and participants gave 
written informed consent.
2.2. Participants
The study sample consisted of 1077 non-
demented elderly persons aged over 60 
years (mean age 70 years, 52% women), 
who were screened for depressive symptoms 
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and underwent structural MRI to assess 
cerebral changes at baseline in 1995–1996. 
Participants were continuously monitored 
by reviewing medical records. Follow-up 
was complete until March, 2000.
Participants with no information on 
depression (n =16), those who screened 
positive but without psychiatric diagnostic 
interview (n =6), and those diagnosed as 
having other psychiatric disorders during 
follow-up (n =8) were excluded.
2.3. Brain infarcts and white matter 
lesions
Axial T1-weighted, T2-weighted, and 
proton density scans were performed 
on 1.5 T MRI scanners. Infarcts were 
defined as focal hyperintensities on T2-
weighted images, Z3 mm (Fig. 1). A 
physician scored infarcts, their location 
and size at baseline. We obtained a history 
of stroke and transient ischemic attack 
(TIA) by self-report and medical records. 
Subsequently, an experienced neurologist 
categorized the MRI-defined infarcts as 
silent or symptomatic (Vermeer et al., 
2007).
We defined SBIs as evidence of one or 
more infarcts on MRI, without a history 
of a corresponding stroke or TIA.
WMLs were considered if visible as 
hyperintense on proton-density and T2-
weighted images, without prominent 
hypointensity on T1-weighted scans. 
Two raters scored periventricular and 
subcortical WMLs independently. 
Severity of periventricular WMLs was 
rated semi-quantitatively in three regions 
(grade range 0–9) (de Leeuw et al., 2001).
2.4. Assessment of depressive disorders
At baseline, we assessed depressive 
Fig. 1. Silent brain infarct and white matter lesions in participants of the Rotterdam Study at baseline. Vascular brain 
changes on 1.5 T MRI are shown. Arrow indicates the abnormality in the image. (A) Periventricular white matter 
lesions on T2 weighted sequence. (B) Subcortical white matter lesions on T2 weighted sequence. (C) Lacunar infarct 
on T1 weighted sequence.
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symptoms with a validated Dutch 
version of the Centre for Epidemiologic 
Studies Depression (CES-D) scale and by 
checking indications of prescribed drugs 
in all the participants. Prevalent depressive 
disorders were defined as depressive 
symptoms (CES-D scores >=16) or the use 
of antidepressant medication at baseline.
Information on recurrent and incident 
depressive disorders during follow-up 
was established by re-examining 787 
participants with the CES-D scale between 
1999 and 2000. Screen positives were 
assessed by a psychiatrist with a Dutch 
version of the Schedules for Clinical 
Assessment in Neuropsychiatry (SCAN), 
to ascertain a Diagnostic and Statistical 
Manual of Mental Disorders-Fourth 
Edition (DSM-IV) depression diagnosis. 
In addition, we continuously monitored 
the general practitioner’s medical records 
and the Regional Institute for Ambulatory 
Mental Health records for depressive 
episodes. Medicals records allow the 
identification of depressed participants 
during the interval between assessments.
Incident depressive disorders were defined 
as depressive disorders during follow-up 
without depression at baseline. Recurrent 
depressive disorders were defined as a 
depressive disorder during follow-up 
in persons with prevalent depression at 
baseline. A history of depression was 
defined as a depressive episode before the 
baseline examination lasting more than 2 
weeks.
2.5. Covariates
Age, sex, education and cognitive 
function assessed by Mini-Mental State 
Examination (MMSE) score were used as 
possible confounders.
2.6. Data analysis
We tested whether the presence of any 
brain infarcts and the severity of WMLs 
were associated with incident or recurrent 
depression with logistic regression. 
Analyses were adjusted for age, sex, 
education, and baseline MMSE score.
Separate analyses were run to test 
the association of symptomatic brain 
infarcts, SBIs, periventricular and 
subcortical WMLs and depression. 
Severe periventricular and subcortical 
WMLs were defined as >= 5 points for 
periven-tricular WMLs and >= 2 ml for 
subcortical WMLs.
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Table 1. Brain infarcts and white matter lesions and the risk of incident depression
or recurrent depression.a
 OR*
1.1
1.0
1.1
1.1
1.3
2.1
95% CI**  OR 95% CI
(0.6–2.9)
(0.5–1.8)
(0.7–1.7)
(1.0–1.2)
(0.6–2.6)
(1.1–3.9)
2.1
2.9
0.8
1.1
1.0
0.9
All infarcts
Asymptomatic infarcts
Symptomatic infarcts
White matter lesions
Severe periventricular
Severe subcortical
Recurrent depressive
disorders (32/86)
Incident depressive
disorders (60/961)
(0.8–5.2)
(1.0–8.2)
(0.1–5.9)
(0.8–1.4)
(0.8–1.2)
(0.3–2.7)
34. All analyses were adjusted for age, sex, education and baseline Mini-Mental State Examination (MMSE) score.
n OR=odds ratio.
nn CI=condence interval.
Additionally, in sub-analyses participants with any history of depression were excluded (n=249). We also 
repeated the analyses aer exclusion of participants who developed dementia during follow-up (n=34).
Brain lesions
3. Results
At baseline, of the 961 participants 
without depressive symptoms, 36 persons 
had symptomatic brain infarcts and 
182 had SBIs. Of the 86 participants 
with depressive symptoms, seven had 
symptomatic brain infarcts and 25 had 
SBIs.
During a mean follow-up of 3.6 years, 60 
(6.2%) participants without depressive 
symptoms and 32 (37%) participants with 
depressive symptoms at baseline were 
diagnosed with depressive disorders.
Symptomatic brain infarcts and SBIs were 
not associated with incident depressive 
disorders in longitudinal analyses. 
However the presence of SBIs at baseline 
almost tripled the risk of recurrent 
depressive disorders (Table 1).
Severe subcortical WMLs doubled the 
risk of incident depressive disorders 
whereas severe periventricular WMLs 
were not related to incident depression. 
WMLs were not associated with recurrent 
depression (Table 1).
112
Chapter 6
Exclusion of participants with history of 
depression and exclusion of participants 
who developed dementia during follow-
up did not change the results (data not 
shown).
4. Discussion
We found that older adults with SBIs had 
an almost three-fold risk of recurrent 
depression. In contrast SBIs were not 
associated with incident depression.
So far only an association between SBIs 
and the prognosis of clinical depression 
has been studied (Vermeer, 2007; 
Yamashita et al., 2001), showing a poor 
long-term prognosis and a decreased 
remission rate in hospitalized patients 
with SBIs. Our findings are in line with 
these studies and suggest that SBIs cause 
depression immediately and lastingly 
but are not associated with a higher risk 
of incident depressive episodes during 
follow-up.
There are several possible explanations 
for the association between SBIs and 
recurrent depression in older adults. 
First, depressive disorders may be a direct 
consequence of ischemic brain damage. 
It is known that damage to small vessels 
supplying subcortical pathways disrupts 
the neurotransmitter circuitry that is 
involved in mood regulation (Zgaljardic 
et al., 2003). Also, the location and nature 
of these lesions may affect individuals 
differently. When the accumulation of 
the infarcts exceeds a certain threshold, 
people could become more vulnerable 
to depression. Second, it has been 
suggested that depression may contribute 
to the evolution of vascular risk factors, 
which in turn increase the risk of 
cardiovascular disease. Following this 
reasoning, the underlying vulnerability to 
depression precipitates the future episode 
independent of the vascular burden.
Our findings showing the association 
between severity of subcortical WMLs, 
which are generally seen as indicating 
ischemia damage, and incident depression 
are in accordance with most other studies.
The observed findings remained after 
exclusion of participants, who developed 
dementia during follow-up (n=34), 
suggesting that associations of SBI and 
WML with depression are not due to 
dementia. Moreover, these associations 
were independent of a history of 
depression, suggesting that vascular brain 
damage precedes the depressive disorder, 
rather than being a consequence of 
depression.
A potential methodological limitation 
of our study is the possibility of 
misclassification. Participants tend to 
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underreport depressive symptoms, and 
physicians probably underdiagnose 
depressive disorders, which may have 
resulted in an under-estimation of the 
true numbers of events. However, in 
addition to information from medical 
records, we actively screened participants 
for the presence of depressive symptoms.
Strengths of this study are its large number 
of elderly people and its prospective 
population-based design.
In summary, our data show that among 
elderly persons the presence of SBIs is 
associated with recurrent depressive 
disorders.
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The vascular depression hypothesis 
postulates that cerebral small vessel 
disease can cause or exacerbate 
depression in elderly persons. Numerous 
studies explored the association of 
imaging markers of cerebral small 
vessel disease including white matter 
lesions (WMLs) and lacunar infarcts 
with depressive symptoms or disorders. 
However, cerebral microbleeds have 
not been tested in depression. In the 
current study, we aimed to explore the 
association of WMLs, lacunar infarcts 
and cerebral microbleeds with depression 
continuum in a large population-based 
sample, the Rotterdam Study. Study 
population consisted of 3799 participants 
(aged 45 or over) free of dementia. WML 
volumes, lacunar infarcts and cerebral 
microbleeds were measured with brain 
Abstract
magnetic resonance imaging. Depressive 
symptoms, depressive disorders and co-
morbid anxiety disorders were assessed 
with validated questionnaires and 
clinical interview. WML volumes and 
lacunar infarcts were associated with 
depressive symptoms and disorders. 
Cerebral microbleeds, especially in deep 
or infratentorial brain regions, were 
related to depressive disorders only. Our 
results indicate that WMLs and lacunar 
infarcts might be non-specific vascular 
lesions seen in depressive symptoms 
and disorders. Association of cerebral 
microbleeds with more severe forms of 
depression may indicate impaired brain 
iron homeostasis or minor episodes of 
cerebrovascular extraversion, which 
may play a role in depression etiology.
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1. Introduction
The co-occurrence of cerebrovascular 
diseases and depression led researchers 
to propose the vascular depression 
hypothesis in late-onset depression. Since 
the hypothesis was first described by 
Alexopoulos et al. (1997) and Krishnan 
et al. (1997), research on the etiology of 
vascular depression has been advanced 
along two conceptually different lines. 
Some researchers have focused on the 
localization of the vascular lesions to 
explain the etiology of the vascular 
depression (Sneed and Culang-Reinlieb, 
2011). Others have explored the cognitive 
deficits due to the vascular cerebral lesions 
predisposing to depression. In the last 
decade, this approach has led researchers 
to define “the depression-executive 
dysfunction syndrome” in which 
symptoms of executive dysfunctions such 
as difficulty with planning, organizing, 
abstracting are seen as part of clinical 
depression (Sneed and Culang-Reinlieb, 
2011; Taylor et al., 2013b). Despite the 
supporting evidence, it is still debatable 
whether the vascular depression exists 
as a clinical entity. Extracerebral vascular 
diseases seem to be less consistently 
associated with depression in elderly than 
to cerebral vascular diseases (Almeida, 
2008; Almeida et al., 2007). While vascular 
risk factors, lesions and diseases are very 
common in elderly, the prevalence of 
depression does not increase in parallel. 
If the vascular depression hypothesis 
was of public health importance (i. e. 
vascular factors strongly predispose, 
precipitate, and perpetuate depression), 
the prevalence of depression in elderly 
would be expected to rise more strongly 
with age (Almeida, 2008).
Early studies have tested the link between 
depression and clinically overt vascular 
events. In these patients, the effects of 
the functional deficits on depression as a 
result of the vascular event are difficult to 
control for.
In a recent report of the Rotterdam Study, 
myocardial infarction was related to 
depression in men, only when recognized 
that supporting the importance of 
psychosocial effects of an overt disease 
(Jovanova et al., 2016).
Nowadays, a narrower definition of 
vascular depression hypothesis is used 
in which the vascular component is 
considered as clinical or non-clinical 
cerebrovascular events. Non-clinical 
vascular events are consisted of imaging 
findings of cerebral small vessel 
disease. Such findings occur as a result 
of hypertension, arteriolosclerosis, 
inflammation or amyloid deposition in 
small arteries, arterioles or venules of 
the brain (Pantoni, 2010). These imaging 
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findings are common in the elderly 
people. The most commonly explored 
imaging findings of cerebral small vessel 
disease are white matter lesions (WMLs) 
and lacunar infarcts. For decades, WMLs 
have been explored in different severity 
degrees of depression. Cross-sectional and 
longitudinal association of WMLs with 
depressive symptoms, major depressive 
disorder (MDD), poor treatment 
response, and occurrence and recurrence 
of MDD (Arnone et al., 2012; Baldwin, 
2005; de Groot et al., 2000; Godin et al., 
2008; O’Brien et al., 1998; Olesen et al., 
2010; Saavedra Perez et al., 2013; Taylor et 
al., 2013a) and comorbid anxiety disorders 
have been demonstrated (Fiedorowicz 
et al., 2011). Similarly, lacunar infarcts 
has been related to depressive symptoms 
(Grool et al., 2013; Wu et al., 2014), MDD, 
and recurrence of MDD (Saa-vedra Perez 
et al., 2013).
Cerebral microbleeds are now recognized 
as an imaging phenotype of the cerebral 
small vessel disease. (de Jong et al., 2002; 
Pantoni, 2010; Poels et al., 2012; Vernooij 
et al., 2008c). Cerebral microbleeds are 
perivascular collections of hemosiderin 
induced by prior tiny hemorrhage. 
Similar to the WMLs and lacunar in-
farcts, cerebral microbleeds are detected 
commonly in elderly (Poels et al., 2010). 
In general, there are two types of cerebral 
microbleeds on the basis of location: 
deep or infratentorial microbleeds and 
lobar microbleeds. Deep or infratentorial 
microbleeds were generally related 
to vascular risk factors whereas lobar 
microbleeds were associated with cerebral 
amyloid angiopathy (Vernooij et al., 
2008b). Cerebral microbleeds and their 
locations have not yet been extensively 
tested in depressive disorders. Studies 
assessing the relation between cerebral 
microbleeds and depressive disorders 
are mostly limited to the stroke cases 
in clinical settings (Tang et al., 2014a, 
2011a, 2011b, 2014b). In a recent 
longitudinal study, it was shown that 
cerebral microbleeds were not related 
to incident depressive symptoms (van 
Sloten et al., 2015). However, the relation 
of cerebral microbleeds with different 
severity degrees of depression including 
depressive symptoms, depressive 
disorders and comorbid conditions of de-
pressive disorders have not been tested in 
general population.
The link between cerebral small vessel 
disease and depressive symptoms has 
been tested in large population-based 
studies. However, the association 
between cerebral small vessel disease and 
depressive disorders was assessed mostly 
in small clinical studies.
In the current study, we aimed to test 
the associations of several imaging 
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phenotypes of cerebral small vessel 
disease with different severity degrees 
of depression including depressive 
symptoms, depressive disorders and 
depressive disorders with comorbid 
anxiety disorders in general population. 
We hypothesized that WMLs, lacunar 
infarcts, and cerebral microbleeds are all 
related to the depression continuum.
2. Methods
2.1. Study sample
This study was embedded in the Rotterdam 
Study, a prospective population-based 
cohort of middle-aged and elderly persons 
(Hofman et al., 2015). From 2005 to 2008, 
a random sample within the Rotterdam 
Study was formed for the regular research 
center visits. They were invited for brain 
magnetic resonance imaging (MRI).
In total 3855 participants were involved. 
Of these, 44 (1.1%) had no depression 
assessment and 10 (0.3%) persons with 
dementia were excluded. This left 3799 
people in the study sample.
Of the 3799 persons in one or more 
analysis, 3741 had a valid WML mea-
surement, 3742 had data on microbleeds 
and 3701 participants had data on lacunar 
infarcts.
The Rotterdam Study has been approved 
by the institutional review board of the 
Erasmus University Medical Center and 
by the review board of The Netherlands 
Ministry of Health, Welfare and Sports. All 
participants provided written informed 
consent after complete description of the 
Rotterdam Study.
2.2. Assessment of depressive symptoms 
and anxiety disorders
We diagnosed depressive disorders with 
a two-step procedure. First, we tested all 
participants for depressive symptoms 
using the Center for Epidemiological 
Studies-Depression (CES-D) scale during 
the home interview at study entry. A cut-
off of 16 was used to define “clinically 
significant depressive symptoms”. This 
cut-off score has a very high sensitivity 
for major depression in older adults in 
the Netherlands (Beekman et al., 1997; 
Radloff, 1977).
In the second step, we invited the 
participants with a CES-D score of 16 
or greater to a semistructured interview, 
the Schedules for Clinical Assessment in 
Neuropsychiatry (SCAN) (Wing et al., 
1990). Clinicians were conducted the 
interviews in close proximity in time to 
screening. Clinical depressive disorders 
included DSM-IV-TR–defined major 
depressive disorder and dysthymia. Thus, 
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both clinically significant depressive 
symptoms and DSM-IV depressive 
disorders were assessed in this study.
To determine participants with depressive 
disorders and comorbid anxiety 
disorders, we used a slightly adapted 
version of the Munich version of the 
Composite International Diagnostic 
Interview (M-CIDI). The interview 
was performed by trained interviewers 
(Wittchen et al., 1998). All DSM-IV 
anxiety disorders including generalized 
anxiety disorders, panic disorder with 
or without agoraphobia, social phobia 
and specific phobia were assessed 
except obsessive-compulsive disorder 
and posttraumatic stress disorder (rare 
and difficult to diagnose reliably in the 
general population). We grouped anxiety 
disorders into a category of “any anxiety 
disorder”.
2.3. Brain MRI
Brain MRI was performed on a 1.5-T 
scanner (GE Healthcare, Milwaukee, WI) 
with an 8-channel head coil including T1-
weighted, proton-density weighted, fluid-
attenuated inversion recovery, and T2*-
weighted gradient echo sequences (Ikram 
et al., 2011).
Post-processing steps have been described 
elsewhere and include a conventional 
k-nearest-neighbor brain tissue classifier 
extended with WML segmentation 
(Ikram et al., 2011). Using this classifier, 
we obtained quantitative measures of 
WML volume and intracranial volume (in 
mL). (Vernooij et al., 2007).
We defined lacunar infarcts as focal 
hyperintensities that are >=3 mm on 
FLAIR and T2-weighted images. An 
experienced physician scored all infarcts.
All scans were reviewed by 1 of 5 well-
trained raters who were blinded to the 
clinical data. Intra-observer (n=500, 
1 rater) and inter-observer (n=300) 
reliabilities were κ=0.87 and κ=0.85, 
which indicates very good agreement. 
In line with previous studies, we defined 
categories of microbleeds restricted to a 
lobar location (strictly lobar microbleeds) 
and microbleeds in a deep or infratentorial 
location (Poels et al., 2011; Vernooij et al., 
2008a).
2.4. Covariate assessment
Age, sex, education, smoking status, 
hypertension, diabetes mellitus, body 
mass index, total and HDL cholesterol 
concentrations and cognitive function 
were used as potential covariates on 
the basis of prior literature (Luijendijk 
et al., 2008). Education was grouped 
into eight categories in an ordinary 
scale from primary education (1) to 
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university level (8) on the basis of the 
Standard Classification of Education. For 
the analyses, we further categorized it 
into three categories; low, intermediate, 
and high. Smoking status was coded in 
categories as never, former and current 
smokers. Systolic and diastolic blood 
pressures were calculated as the average 
of two consecutive measurements. 
Hypertension was defined as a systolic 
blood pressure >=140 mm Hg or a 
diastolic blood pressure >= 90 mm Hg or 
the use of antihypertensive medication 
according to pharmacy records. Data on 
diabetes mellitus was collected on the 
basis of the general practitioners’ reports 
and the assessment at the research center. 
Participants were considered as having 
prevalent diabetes when they had at least 
one of the following four criteria: plasma
glucose  concentration  >= 7.0 mmol/L, 
random plasma glucose concentration 
>= 11.1 mmol/L, antidiabetic medication, 
and/or diabetes treatment by diet. Height 
and body weight were measured. Body 
mass index was calculated as weight in 
kilograms divided by height in meters 
squared. Cholesterol levels were evaluated 
with an automated enzymatic procedure. 
Cognitive function was assessed with the 
Mini-Mental State Examination (MMSE) 
(Folstein et al., 1975). 
2.5. Statistical analyses
We log-transformed the WML volumes 
to achieve a normal distribution. WML 
volumes were used as continuous 
measures and lacunar infarcts and 
cerebral microbleeds were used as binary 
variables.
To evaluate the cross-sectional 
associations of the imaging phenotypes 
of cerebral small vessel disease with 
depression continuum, we performed 
a series of analyses. First, we modeled 
depressive symptoms score continuously 
(the CES-D score) and tested the 
associations between the cerebral small 
vessel disease and depressive symptoms 
score with linear regression analyses. 
Second, we used a predefined cut-off of 16 
for the CES-D to detect participants with 
clinically significant depressive symptoms 
and tested the associations of cerebral 
small vessel disease with clinically 
significant depressive symptoms using 
logistic regression analyses.
Third, we examined the associations of 
the cerebral small vessel disease with the 
DSM-IV depressive disorders (major 
depressive disorder and dysthymia) with 
multinomial logistic regression. In these 
latter analyses, participants below the 
CES-D score of 16 formed the reference 
category. All analyses were adjusted for 
123
Markers of cerebral small vessel disease and severity of depression in the general population
age and gender. Analyses were further 
adjusted for education, smoking status, 
hypertension, diabetes mellitus, total 
and HDL cholesterol concentrations 
and MMSE score except for lacunar 
infarcts because of small sample size. 
Analyses of cerebral microbleeds were 
additionally adjusted for WML volume 
and intracranial volume. Analyses of 
WML volume were further adjusted for 
intracranial volume.
Next, we tested whether any associations 
of cerebral microbleeds with depression 
depended on the localization of 
microbleeds using strictly lobar and 
infratentorial microbleeds categories.
In the sensitivity analyses, we explored 
if the associations of cerebral small 
vessel disease with MDD differed 
between persons with a comorbid 
anxiety disorder and those with MDD 
only; we used the group of persons 
without depressive symptoms as the 
reference group for the multinomial 
logistic regression analyses testing this 
difference. These sensitivity analyses 
were adjusted for age and gender.
Analysis of WML volume was adjusted 
for intracranial volume and analysis of 
cerebral microbleeds was adjusted for 
intracranial volume and WML volume.
We imputed the missing values on 
covariates using expectation maximization 
algorithm. Missing values on covariates 
were minimal (maximum, 3.1%). The 
SPSS software (version 20; SPSS, Chicago, 
Illinois) was used for statistical analyses.
3. Results
Characteristics of the study population 
(n=3799) are presented in Table 1. Mean 
age was 58.7 years (standard deviation 
[SD] =07.8) and 2070 (54.5%) participants 
(n=2070) were women. In total 322 (8.5%) 
participants had clinically significant 
depressive symptoms, 60 (1.6%) 
participants had prevalent depressive 
disorders according to the DSM-IV. Of 
the 60 participants with major depressive 
disorder, 31 (51.7%) had a comorbid 
anxiety disorder.
Table 1. Characteristics of the study population.
58.7 (7.8)
2070 (54.5)
438 (11.5)
2411 (63.5)
950 (25)
1429 (37.6)
1152 (30.3)
1218 (32.1)
304 (8)
1834 (48.3)
831 (21.9)
5.6 (1)
1.4 (0.4)
27.5 (4.2)
28.1 (1.7)
5.3 (7)
322 (8.5)
60 (1.6)
538 (14.4)
371 (9.9)
167 (4.5)
4.3 (7)
1125.7 (123.4)
184 (4.8)
98 (2.6)
Age, years, mean (SD)
Women, n (%)
Education, n (%)
Low 
Intermediate
High 
Smoking status, n (%)
Current smoker
Former smoker
Never smoked
Diabetes mellitus (yes), n (%)
Hypertension, n (%)
Lipid lowering medication, n (%)
Total serum cholesterol, mmol/l, mean (SD)
Serum HDL cholesterol, mmol/l, mean (SD)
Body mass index (kg/m2), mean (SD)
Mini mental state examination score, mean (SD)
Depressive symptom score, mean (SD)
Clinically signicant depressive symptoms, n (%)
Depressive disordersa, n (%)
Cerebral microbleeds (yes), n (%)
Strictly lobar microbleeds, n (%)
Deep or infratentorial microbleeds, n (%)
White matter lesion volume, ml, mean (SD)
Intracranial volume, ml, mean (SD)
Lacunar infarcts (yes), n (%)
Cortical infarct (yes), n (%)
Study sample
N=3799
a Depressive disorders category includes persons with major depressive disorder or dysthymia.
Characteristics
125
Markers of cerebral small vessel disease and severity of depression in the general population
A larger WML volume was positively 
related with the severity of depressive 
symptoms as indicated by the higher 
CES-D scores in the fully adjusted model 
(regression coefficient per ml increase 
in WML volume=0.44; 95% Confidence 
Interval [CI] =00.14; 0.75; P =0.005). 
Presence of lacunar infarcts was related 
with high CES-D scores (regression 
coefficient for yes versus no=1.07; 95% 
CI=0.04–2.11, P =0.04). There was no 
association of the presence of cerebral 
microbleed (regression coefficient for 
yes versus No=0.17; 95% CI= 0.48 0.81; 
P =0.61) with the severity of depressive 
symptoms. 
Second, we assessed the associations of 
the cerebrovascular determinants with 
clinically significant depressive symptoms 
(CES-D Z16). Table 2 shows that, 
consistent with the continuous analyses, 
WML volume was positively associated 
with clinically significant depressive 
symptoms. Neither lacunar infarcts nor 
cerebral microbleeds were related with 
clinically significant depressive symptoms.
Next, we evaluated the association of the 
imaging phenotypes of cerebral small 
vessel disease with DSM-IV depressive 
disorders.
An increase in WML volume was 
associated with an increased likelihood 
of DSM-IV depressive disorders (Odds 
Ratio [OR] per ml=1.40; 95% CI=1.20–
1.62; P<0.001). Presence of microbleeds 
increased the likelihood of having 
DSM-IV depressive disorders 40% in 
the fully adjusted model (OR=1.40; 95% 
CI=1.01–1.94; P=0.04). Presence of 
lacunar infarcts was related to depressive 
disorders (OR=1.78; 95% CI=1.07–2.95, 
P =0.03). In the follow-up analyses, we 
categorized cerebral microbleeds as 
deep/infratentorial cerebral microbleeds 
(n=167, 4.5%) or strictly lobar cerebral 
microbleeds (n=371, 9.9%). We found 
a borderline association of deep/
infratentorial cerebral microbleeds with 
depressive disorders (OR=1.41; 95% 
CI=1.0–1.99, P =0.05). There was no 
association between strictly lobar cerebral 
microbleeds and depressive disorders 
even though the effect size was similar 
with the results of the deep/infratentorial 
cerebral microbleeds and depressive 
disorders (OR=1.47; P=0.72).
 
3.1. Sensitivity analyses
We examined whether markers of 
cerebral small vessel disease were related 
to depressive disorders with comorbid 
anxiety disorders. Presence of cerebral 
microbleeds was related to increased 
likelihood of depressive disorders with 
(OR=2.15; 95% CI=1.65–2.81, P<0.001). 
WML volume and presence of lacunar 
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infarcts were not related to depressive 
disorders with comorbid anxiety. 
Discussion
In this population-based study, the 
imaging markers of cerebral small 
vessel disease were differently related to 
depressive symptoms and disorders. WML 
volumes were consistently associated to 
depressive symptoms and MDD. Cerebral 
microbleeds were related to depressive 
disorders only, in particular to depressive 
disorders with comorbid anxiety. In 
the last two decades, WMLs have been 
studied in persons with depression. 
Investigators repeatedly demonstrated the 
association of WMLs with clinical and 
non-clinical presentations of depression. 
This suggests that WMLs are relatively 
non-specific vascular pathologies seen 
in people with depressive symptoms or 
clinical depression and even in other 
common psychiatric disorders including 
anxiety and dementia (Arnone et al., 
2012; Costanza et al., 2012; de Groot 
et al., 2000; Liao et al., 2014; Menzies 
et al., 2008; Saavedra Perez et al., 2013; 
Taylor et al., 2013a; Teodorczuk et 
al., 2007, 2010). Also, lacunar infarcts 
were related to depressive symptoms 
and depressive disorders in the current 
study. Previous studies mostly explored 
the association of lacunar infarcts with 
depressive symptoms. In contrast, studies 
of DSM-IV depressive disorders are 
limited. Silent lacunar infarcts, especially 
when located in the basal ganglia, were 
related to depressive symptoms in a 
small clinical study (Wu et al., 2014). A 
recent population-based study showed 
that subcortical infarcts predict incident 
depressive symptoms (van Sloten et al., 
2015). Another study of patients with 
atherosclerosis demonstrated that lacunar 
infarcts in deep white matter were related 
with an increase of depressive symptom 
severity and a more fluctuating course 
of depressive symptoms during follow-
up (Grool et al., 2013). In the Rotterdam 
Study, we previously reported that silent 
brain infarcts predict the recurrence of 
clinical depression (Saavedra Perez et al., 
2013).
The underlying mechanism for the 
relation of WMLs and lacunar infarcts 
with depression might be the detrimental 
local effects of cerebral small vessel 
disease in the frontostriatal and limbic 
regions. These local damages disrupt 
the neurotransmitter circuitry involving 
in mood regulation (Alexopoulos, 
2002; Baldwin and O’Brien, 2002). 
This is supported by observation in the 
current and previous studies that the 
subcortical WMLs and lacunar infarcts 
are consistently related to depression (de 
Groot et al., 2000; Herrmann et al., 2008; 
Saavedra Perez et al., 2013).
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Cerebral microbleeds have not been 
tested in relation to different severity 
degrees of depression in a non-clinical 
sample. Previously, Tang and colleagues 
(Tang et al., 2011a, 2011b) explored 
cerebral microbleeds in patients with 
stroke and found that the presence of 
cerebral microbleeds was related to post-
stroke depression. In a longitudinal study 
of elderly people in general population; 
van Sloten et al. detected no association 
between cerebral microbleeds and 
incident depressive symptoms (vanSloten 
et al., 2015). In our population-based 
study, we observed an association of 
cerebral microbleeds with depressive 
disorders in participants free of stroke. 
Also, there was a relation between cerebral 
microbleeds and depressive disorder with 
comorbid anxiety, which indicates a more 
severe form of depression. 
This effect was not found when we test 
the association of cerebral micro bleeds 
with depressive symptoms although 
continuous analyses generally have more 
power to detect the associations. This 
suggests that cerebral microbleeds may be 
a specific vascular pathology only seen in 
the most severe form of depression.
Localization of cerebral microbleeds is 
of importance because they do not only 
signal an impact on different anatomical 
regions but this may also reflect different 
underlying pathological processes of the 
vascular pathology. Lobar microbleeds 
are generally related to cerebral amyloid 
angiopathy whereas deep infratentorial 
cerebral microbleeds are associated 
with hypertensive microangiopathy 
(Vernooij et al., 2008b). We found that 
deep/infratentorial microbleeds, which 
are related to cardiovascular risk factors, 
were associated to depressive disorders. In 
contrast, lobar microbleeds indicating an 
amyloid angiopathy were not associated 
with depressive disorders even though the 
effect size was similar with the analyses of 
deep/infratentorial microbleeds. Overall, 
our findings support a vascular etiology 
of depression rather than an involvement 
of the amyloid pathway in the pathology 
of depression.
These explanations discussed above 
imply that the direction of mechanisms 
is from cerebral small vessel disease to 
depression (Direk et al., 2012; Herrmann 
et al., 2008; Saavedra Perez et al., 2013; 
Teodorczuk et al., 2010). However, it 
has also been suggested that there is a 
bidirectional association between small 
cerebral vascular disease and depression. 
The mechanisms by which depression 
may contribute developing cerebral 
small vessel disease increase are not 
completely understood, but biological 
(atrophy in different brain regions, the 
hypothalamic-pituitary-adrenal axis
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dysfunction, inflammation) and lifestyle 
changes (poor health, smoking, less exercise) 
during depressive episodes are thought 
to be risk factors to cerebral small vessel 
disease (Gothe et al., 2012; Poels et al., 
2010; Schmidt et al., 2013; Wardlaw et al., 
2013).
The current study has several strengths. 
First, the study was based on general 
population, enhancing the external 
validity of the findings. Second, we 
evaluated both depressive symptoms 
and depressive disorders. Depressive 
disorders were diagnosed with a clinical 
psychiatric interview in this population-
based study. Additionally, depressive 
disorder with comorbid anxiety disorder 
that is considered a more severe form of 
depression was tested.
 
Evaluating anxiety disorders is not 
common in population-based studies. 
Third, large study sample in the analyses 
of depressive symptoms allowed us to test 
several covariates. Finally, we were able 
to evaluate different imaging markers 
of cerebral small vessel disease, which 
allowed us to explore different aspects 
and mechanisms of cerebral small vessel 
disease such as ischemia and hemorrhage 
in the same sample.
There are also some limitations that 
should be considered when interpreting 
the results. Firstly, this study was not 
longitudinal. We discussed above that the 
direction of the temporality is unclear. In 
the further studies, cerebral microbleeds 
needs to be tested longitudinally to 
interpret if these associations are causal. 
Secondly, number of participants with 
depressive and anxiety disorders was low, 
yet we had enough power to detect the 
association of cerebral small vessel disease 
and depressive disorders.
In conclusion, our study supports vascular 
depression hypothesis. Three imaging 
markers of cerebral small vessel disease 
in later life were consistently associated 
to depressive symptoms and depressive 
disorders. Our study suggests that deep 
infratentorial microbleeds can index 
impaired brain iron homeostasis or minor 
episodes of cerebrovascular extraversion 
in persons with depressive disorders 
but more studies are needed to provide 
evidence on the exact mechanisms and 
the nature of cerebral small vessel disease 
in depression.
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Discussion
Prolonged grief and cognition
Worldwide there are more than 60 million 
deaths each year (1), and an average of 
four survivors per death (2). Bereavement 
and the experience of grief are considered 
one of the most stressful life’s events 
(3). Despite this, most bereaved adults 
will cope with the loss after the initial 
weeks and months following the loss (4); 
however, about 9-20% of the persons 
cannot cope with the death of a loved one 
and will present a chronical condition 
with suffering pain and disruption for 
years after the loss (5,6). 
This condition were first called 
SUMMARY
MAIN FINDINGS
In this thesis, I investigated the associations 
between prolonged grief disorder (PGD) 
and different domains of cognition and 
with brain volumes assessed by MRI in 
a middle-aged and elderly population. I 
also compared cognitive decline, morning 
cortisol and summary cortisol measures, 
and sleep quality as well as sleep duration 
between persons with normal grief, 
persons with PGD, and persons from a 
non-grieving reference group. Finally, 
I aimed to test the association of non-
clinical cerebral small vessel disease with 
depression longitudinally in general 
population.
In this chapter, I will review the main 
findings of the studies. Next, I will address 
some methodological considerations, 
clinical implications, and make 
suggestions for future research.
complicated grief (CG) by experts, and 
later prolonged grief disorder (PGD). The 
association of grief with cognitive deficits 
has been studied for many years (7-9). 
Only a few years ago, the relation of PGD 
with cognitive functioning attracted the 
interest of scientists, but up to this day 
the cognitive impact of PGD on a person’s 
health is not well-known.
In the Rotterdam Study, the most 
common cause of grief and PGD was the 
death of a partner. Grieving participants 
were more likely to be female, were older, 
had more depressive symptoms, poorer 
cognitive functioning, and were more 
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likely to have a history of depression, 
stroke and diabetes. 
In chapter 2, I explored the cross-sectional 
association of PGD with cognitive 
performance, and tested whether there 
are differences in brain volumetric 
measures between persons with and 
without symptoms of prolonged grief. 
In a population of 5501 non-demented 
persons, I found an association between 
PGD and poor cognitive performance. 
If compared to non-grievers and normal 
grievers, persons with PGD had lower 
scores on Letter-Digit Substitution test 
and Word Fluency Task.
In addition, I found that persons with PGD 
were more likely to have a smaller total 
brain volume. It is important to mention 
that in this study I excluded participants 
with major depression and controlled the 
analyses for depressive symptoms, thus 
ensuring that depression, which is related 
both to cognitive performance and brain 
characteristics did not confound the 
results.
These results, for the first time, provide 
evidence for an underlying neurobiological 
mechanism for the relation between PGD 
and cognitive functioning. The Word 
Fluency Task is considered to be related 
to the intact function of the frontal 
cortices and the medial temporal areas 
(13,14), and the LDST is sensitive to more 
global changes in brain function (15); 
performances in both tests were affected 
in persistently grieving persons in our 
study. Participants with PGD were also 
characterized by more brain atrophy, 
whereas the white matter lesion volumes, 
which reﬂect vascular brain damage, 
did not differ between the groups. These 
results could suggest that differences 
in structural brain volumes could be a 
consequence or a precipitating factor of 
PGD. The   observed atrophy may reflect 
a vulnerability to developing PGD, as 
previous studies showed atrophy is related 
to cognitive functioning and coping 
(13,14). The smaller total brain volume 
and the cognitive differences imply that 
neuronal loss may have disrupted the 
microstructural integrity of the fascicles 
connecting the prefrontal cortex with the 
cortical (frontal, temporal and occipital 
lobes) and the subcortical areas (amygdala 
and hippocampus), and even in the 
functioning of corticostriatal circuitry 
(16). Reduced cerebral connectivity 
could explain the prolonged resolution 
of grief in older adults as well as the poor 
performance in cognitive tests. 
However, equally, the cognitive impairment 
may be a consequence of PGD. In 2012, 
O’ Connor showed that the regional brain 
activation to grief cues frequently includes 
the dorsal anterior cingulate cortex and 
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the insula, as well as the posterior cingulate 
cortex (17). The anterior cingulate cortex, 
speciﬁcally the anterior cingulate gyrus, 
is part of an executive attention network, 
its main role is to regulate the processing 
of information from other networks, 
both sensory and emotional modalities 
(17-22). The regional neural activation 
of the dorsal anterior cingulate gyrus, 
insula, and posterior cingulate cortex in 
persons with PGD could be the cause of 
a persistent deregulation in the network 
processing grief. 
In chapter 3, I compared cognitive decline 
between persons with normal grief or 
PGD, and a non-grieving reference 
population in a 7-year follow-up study. 
As in my first study, the main cause for 
grieving in participants with PGD was 
the death of a partner. Although previous 
cross-sectional studies of bereavement and 
cognition demonstrated poor cognitive 
performance in persons with grief and 
PGD (7-9,12, 23); none of these studies 
examined cognitive decline on PGD over 
time. The participants with PGD showed 
a stronger cognitive decline (decrease in 
global cognitive function, MMSE scores, 
and World learning test (immediate and 
delayed)) over time than the reference 
group. The delayed recall test has a high 
sensitivity and specificity to differentiate 
early stages of cognitive impairment from 
cognitive performance in normal elderly, 
and is more accurate than the MMSE (24-
25). In particular, total immediate recall 
and delayed recall were found to be robust 
predictors of mild cognitive impairment 
before converting to Alzheimer’s disease 
within 3 years of follow-up (26). However, 
I found no evidence that persons with 
normal grief, thus after the exclusion of 
persons with PGD from this group, show 
evidence of faster cognitive decline. These 
findings were in line with our hypothesis, 
that grief, if unrelated to pre-existing 
vulnerabilities, is a normal life event from 
the persons typically recover.
In chapter 4, I determined the association 
of PGD with sleep duration and sleep 
quality. Studies have shown that 
bereavement was associated with lower 
sleep quality (27-30). In this study, PGD 
was associated cross-sectionally with 
shorter sleep duration and lower sleep 
quality, in accordance with previous 
studies (31,32), but no association 
was found longitudinally. The sleep 
disturbances were mainly explained by 
depressive symptoms. The measure of 
depressive symptoms is not specific, 
thus the sleep disturbances might also be 
explained by the difficulty imagining and 
planning the future, a subjective sense of 
having a hopeless or foreshortened future 
(33-35), the intrusive memories about the 
deceased (36,37) or rumination (i.e., a 
style of perseverative thought on negative 
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emotions and the meaning of those 
emotions) (38-40).
In chapter 5, I examined the association 
of morning cortisol and summary 
cortisol measures with prevalent grief and 
prolonged grief hat occurred in a period 
of two years.  I found that participants 
with PGD had lower levels of morning 
cortisol and lower overall diurnal cortisol 
levels. In contrast, persons with normal 
grief showed similar cortisol secretion 
patterns as those without grief. Cortisol 
is frequently referred to as the “stress 
hormone”, and is secreted when the 
hypothalamic–pituitary–adrenocortical 
axis HPA is stimulated (41). However, 
hypocortisolism has also been observed 
in patients, who developed post-
traumatic stress disorder (PTSD) (42,43), 
or chronic diseases (44-46). Persons 
with PGD experience severe stress and 
perceive their loss like a major trauma. 
The results confirm my hypothesis based 
on prior studies that persons undergoing 
prolonged grief have an adaptive down-
regulation of cortisol. I postulate that 
this is due to reduced biosynthesis 
leading to hypocortisolism (42,44). 
Another explanation would be the effects 
of chronic stress on neuronal loss. In 
chapter 2, I demonstrated that persons 
with PGD had lower brain volumes, 
and that chronic stress could reflect 
neurodegeneration. Neuronal loss may 
disrupt the microstructural integrity of 
the fascicles connecting prefrontal cortex 
with the subcortical areas (amygdala and 
hippocampus) (45,46), which are involved 
in the inhibitory regulation of the HPA 
axis (44,47,48). In addition, the smaller 
brain volumescould also affect struictures 
like the hippocampus or hypothalamus, 
which are involved in the inhibitory 
regulation of the HPA axis (49,59).
No association of grief or PGD with 
cortisol secretion patterns was observed, 
if persons with longer periods since the 
loss were included. This suggests that 
participants with more than two years 
post loss may have adapted to the loss and 
the resulting changes. 
Several studies proposed that CG 
reactions only persist when people 
engage in avoidance behaviors trying to 
impede habituation to painful memories 
and interfering with the integration of 
the loss (51). It is important to highlight 
that cortisol is involved in cognitive 
functions such as memory performance 
and executive function (52,53). My results 
thus might imply that persons with PGD 
may be more vulnerable to develop 
cognitive impairment. In summary, the 
results in this chapter offer an intriguing 
explanations for earlier findings.
In chapter 6, I tested the association 
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of non-clinical cerebral small vessel 
disease with depression longitudinally 
in the general population. A relationship 
between cerebrovascular disease and 
depression in the elderly has been 
established two decades ago (54). Studies 
provided evidence that subclinical 
cerebrovascular disease is associated with 
depression (55-57). In accordance to these 
results, I found that older adults with 
silent brain infarcts had an almost three-
fold risk of recurrent depression episode 
during a mean follow-up of 3.6 years. 
The study suggests that the associations 
of silent brain infarcts and white matter 
lesions with depression is not due to 
dementia; and is independent of a history 
of depression, suggesting that vascular 
brain damage precedes the depressive 
disorder, rather than being a consequence 
of depression. The damage to small vessels 
supplying subcortical pathways disrupts 
the neurotransmitter circuitry that is 
involved in mood regulation (58). Also, 
when the accumulation of the infarcts 
exceeds a certain threshold, people could 
become more vulnerable to depression. 
In chapter 7, I explored crossectionally 
the association of WMLs, lacunar infarcts 
and cerebral microbleeds with different 
severity degrees of depression. White 
matter lesions volumes and lacunar 
infarcts were associated with depressive 
symptoms and major depressive 
disorders. Cerebral microbleeds, 
especially in deep or infratentorial 
brain regions, were related to depressive 
disorders in stroke-free participants. 
Deep/infratentorial cerebral microbleeds 
have been related to cerebrovascular 
risk factors and hypertension, whereas 
strictly lobar microbleeds are related to 
cerebral amyloid angiopathy. Alterations 
or defects in the autoregulation of the 
cerebral blood flow can cause vascular 
lesions many years before the clinical 
onset of a cerebrovascular disease. 
Deficits in cerebral perfusion may 
affect protein synthesis important 
for cognitive networks and synaptic 
plasticity (59,60). The results indicate 
that WMLs and lacunar infarcts might 
be non-specific vascular lesions seen in 
depressive symptoms and disorders; and 
are consistent with previous studies that 
showed an association between WML and 
depression (61-63). 
Similarly, silent brain infarcts related 
with depression in late life has been 
demonstrated in previous studies (64-66).
Taken together, these results provide 
little evidence for specific effects of grief, 
prolonged grief disorder or depression 
on brain morphology. Rather, persons 
with signs of neurodegeneration are 
likely to be more susceptible for grief and 
depression. Furthermore, many of our 
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findings could be explained by external 
factors, in particular pre-existing disease. 
This is encouraging news for many 
elderly persons experiencing episodes 
of poor mental health, as this suggests 
that typically, these will not have lasting 
neurodegenerative effects as can be 
determined with current neuroimaging 
techniques.
Methodological considerations
Normal grief is experienced as a distressing 
event, usually with an initial state of shock 
followed by acute emotional or somatic 
discomfort and social withdrawal. But 
eventually, most mourning persons 
learn to accept the loss and reassume 
their previous levels of functioning, find 
a sense of meaning and purpose, enjoy 
social activities, feel hopeful about the 
future, and in general, function without 
significant impairment or acute distress. 
In contrast, persons with prolonged 
grief disorder remain severely distress 
for several months or years following the 
death (67).
At the beginnings of the 90s, the absence of 
a scale to assess symptoms of complicated 
grief (CG) made it difficult to investigate 
its’ incidence, prevalence, risk factors 
and consequences. The most commonly 
used grief scales were too broad or 
over-inclusive with respect to CG. The 
assessment of CG was confounded by the 
inclusion of measures of general grief, 
depression, and anxiety. Scales such as the 
Texas Revised Inventory of Grief (TRIG) 
(68) included only benign symptoms 
of grief, leaving out symptoms of CG. 
The Grief Measurement Scale (GMS) 
(69) included symptoms associated 
with anxiety disorders and contained 
depressive items. At the same time, grief 
scales were underinclusive with respect 
to symptoms of CG. Scales such as the 
TRIG and the GMS omitted most of the 
more potentially threatening symptoms 
of prolonged grief disorder. Symptoms 
such as survivor guilt, bitterness over the 
death, jealousy of others who have not 
experienced a similar loss, distraction to 
the point of disruption in the performance 
of one’s normal activities, and lack of trust 
in others because of the loss were not 
assessed in existing scales of grief (70).
All this led to the need to develop a tool 
that could accurately identify grief-related 
symptoms that could help to discriminate 
between uncomplicated and prolonged 
grievers.
In 1995, Prigerson et al (70) developed 
the Inventory of Complicated Grief 
(ICG). The instrument consists of 19 
first-person statements concerning the 
immediate bereavement-related thoughts 
and behaviors of the client. There are five 
response options (0 = never; 1 = rarely; 
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2 = sometimes; 3 = often; 4 = always) 
with which they describe currently 
experienced each of the emotional, 
cognitive, and behavioral states described 
in the PGD. Asking respondents to report 
the frequency of an emotional or cognitive 
state is an effective means by which to 
assess the impact of events (71).
The evaluated symptoms on the ICG 
include symptoms of separation distress 
(intrusive thoughts or preoccupation 
for the deceased, yearning for the 
deceased, searching for the deceased or 
loneliness), and symptoms of traumatic 
distress (loss of identity, emptiness, 
avoidance of memories, anger, sensation 
that life has no meaning, numbness or 
detachment, feeling shocked or dazed, 
bitterness, disbelief about the death). 
The constellation of symptoms needed 
to persist a minimum of 6 months, 
since longitudinal studies indicate that 
symptoms have generally stabilized by 
this point (67).
The ICG is considered the ‘gold standard’ 
for measurement of CG in older adults 
because it has high internal consistency, 
with an alpha coefficient of .94, and good 
convergent and criterion validity. In 
addition, this scale has a well-validated 
clinical cut point. Persons who score over 
25 are significantly more impaired in 
social, general, mental and physical health 
functioning and in bodily pain than those 
with ICG scores less than or equal to 25.
We asked 17 questions. One item from 
the original English inventory, ‘I feel bitter 
over this person’s death’, was removed as 
a pilot study revealed that this sentiment 
had a very similar meaning within the 
Dutch language as the included item: ‘I 
feel anger over this person’s death’. Two 
further items (relating to seeing and 
hearing the deceased) were combined 
into one due to their low frequency of 
endorsement by largely the same persons. 
A summary score for the ICG was 
calculated by totaling each individual 
item score across the 17 items providing 
a potential score range of 0 to 68. 
Participants with a score of less than 22 
were consider as participants with grief 
symptoms. Participants with a score of 22 
or greater and with symptoms reported 
for at least 6 months were considered to 
have CG, The non-grieving control group 
included persons who had experienced 
bereavement in the past but were not 
grieving at the time of interview. Likewise, 
persons grieving for a pet or a loved one 
with a severe disease were included in the 
control group. This cut-off was based on 
the cut-off in the original version of the 
ICG. The original cut-off was 25 from 19 
items) (72). 
Subsequently the term prolonged grief 
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disorder (PGD) is introduced. An 
additional short assessment instrument 
with 13 items (including two severity 
questions) has been introduced to 
establish PGD . Seven of the eleven items 
correspond to items in the ICG. 
The terms CG and PGD were proposed 
to be included in the 5th edition of 
the DSM and 11th edition of the ICD. 
Based on proposals for PGD and CG, 
DSM-5 introduced criteria for persistent 
complex bereavement disorder (PCBD) 
representing a mixture of PGD and CG 
(73).
Prolonged grief disorder and depression
In our studies PGD often did not have 
a predictive value independent of 
depression. Several studies have been 
conducted to examine whether PGD 
symptoms are distinct from depression. 
The etiology, symptomatology, course, 
response to treatment, and adverse 
outcomes of PGD have repeatedly 
been shown to be different from major 
depressive disorder. 
First, studies have shown that yearning 
loads highly on the grief factor, but 
not on depression or anxiety factors, 
whereas sadness loads highly only on a 
depression factor, and feeling nervous 
and worried loads highly only on an 
anxiety factor (70,74). One study with 
functional magnetic resonance imaging, 
demonstrated that both, normal grievers 
and persons with PGD, showed pain 
related neural activity in response to 
reminders of the deceased, but only 
persons with PGD showed reward-related 
neural activity in the nucleus accumbens, 
which was positively associated with self 
report yearning (75). 
Second, studies of negative cognitions 
among bereaved persons found that being 
overwhelmed by the loss and an intense 
preoccupation related to the loss of the 
loved one - are a cognition specific to 
prolonged grief disorder, but not specific 
to depression. In contrast, persons with 
depression exhibit a generalized misery 
and a pessimistic rumination. Likewise, 
global guilt or a sense of personal 
worthlessness, common in depression, is 
not part of PGD, were guilt is specific only 
to the circumstances of the death event 
(76,77).
Third, attachment issues are associated 
with vulnerability to develop PGD. 
Studies show that feelings of emotional 
dependency on the dying patient are 
associated with symptoms of grief, but 
not with symptoms of depression in 
recently bereaved persons. Moreover, at 
least one risk factor, separation anxiety 
in childhood, uniquely predicts PGD but 
not major depressive disorder, generalized 
anxiety disorder, or posttraumatic stress 
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disorder, following bereavement later in 
life (77,78). 
Fourth, three studies investigated the 
facets of negative self-processing in PGD, 
and revealed that PGD is characterized by 
self-devaluation and negative self-related 
cognitions about the future; showing a 
cognitive-affective processing profile that 
is distinct from major depression disorder 
(79). 
Fifth, the course and response to 
treatment of persons with PGD differ 
from those with normal grief and 
depression. Tricyclic antidepressants 
alone and interpersonal psychotherapy 
have proven ineffective for the reduction 
of PGD symptoms, although it produces 
a therapeutic effect on major depressive 
symptoms in the bereaved. On the other 
hand, randomized, controlled trials of 
specific therapy designed for PGD have 
demonstrated a favorably response in 
patients if compared with interpersonal 
therapy or supportive counseling, and 
symptoms of prolonged grief showed 
faster reduction in the groupw receiving 
grief therapy (77,78).
Prolonged grief disorder and cognition
Although there has been substantial 
research on the effects of normal grief 
on cognitive functioning, only a few 
investigated the relation of prolonged 
grief disorder with cognitive deficits (9-
12). Two of them studied the performance 
of persons with PGD on an emotional 
Stroop test, in which persons were 
presented with death-related and neutral 
cue words. Both studies showed a slower 
reaction time to grief related words in 
the PGD group (10,11). This pattern 
of findings suggests an attentional bias 
towards loss-related events.
Another study (12), examined global and 
domain-specific cognitive functioning 
in persons with PGD, assessed using the 
Montreal Cognitive Assessment (MoCA). 
They show that PGD had lower total 
MoCA, visuospatial and attention scores 
relative to control participants. 
In our research, we performed several 
cognitive test (Mini Mental State 
Examination (MMSE), Letter-Digit 
Substitution test (LDST), Stroop test, 
Word fluency task, Word learning test), 
to evaluate cognitive performance and 
cognitive decline in our population data. 
In cross-sectional analyses we found that 
persons with PGD had lower scores on 
Letter-Digit Substitution test and Word 
Fluency Task. Given the cross-sectional 
nature of this study, we are unable to 
determine the causal direction between 
PGD and cognitive functioning. Having 
prolonged grief disorder may increase 
cognitive impairment in older adults 
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or having cognitive impairment may 
increase the likelihood of developing 
prolonged grief disorder after the death of 
the loved one.
Next, we evaluated the cognitive decline 
longitudinally, showing that participants 
with PGD had a stronger cognitive decline 
(decrease in global cognitive function, 
MMSE scores, and World learning test 
(immediate and delayed)) over time, 
compared with the reference group.
At the first glance, we - like others - 
assumed that a correlation between 
PGD and poor cognitive functioning 
implies that PGD is a causal factor for 
cognitive decline. Not only did we find 
evidence for an association between 
PGD and poor cognitive functioning; 
second, PGD apparently preceded the 
onset of cognitive decline, and third, we 
found it unlikely that this was spurious 
relationship. However, it is not that simple 
to be certain about the temporality of this 
relation, as is the case for the relation with 
many chronic diseases with a not clearly 
distinguishable clinical prodomic phase, 
like dementia.
We also found that participants with PGD 
have smaller total brain volumes, produced 
mostly by a reduction in white matter. 
Could our findings thus indicate the 
presence of a mild cognitive impairment 
(MCI) before the development of the 
prolonged grief disorder? Mild cognitive 
impairment (MCI) is regarded as a 
precursor to dementia, but not all patients 
with MCI will develop dementia. Could 
it be that MCI is a vulnerability factor to 
develop PGD in older adults? Is important 
to emphasize that not all individuals with 
MCI will convert to dementia: up to 40–
70% of the patients with a MCI improve, 
stay stable at follow-up (80) or develop 
other age-related neuropsychiatric 
conditions.
In our cross-sectional study, the 
performance in the Mini Mental State 
examination (MMSE) was not affected. 
Some studies revealed that the MMSE is 
not sensitive to subtle neuropsychological 
impairment (81). Thus it is noteworthy 
that in our longitudinal study, we found a 
cognitive decline and a poor performance 
in MMSE, indicating that the progression 
of the cognitive disease is less subtle or 
this measure is sensitive to change.
I postulate that MCI, with its 
characteristically poor cognitive 
function could interfere with the coping 
flexibility abilities of the persons, leads 
to vulnerability to develop PGD. Studies 
suggest that deficits in coping flexibility 
are indicative of PGD (82).The ability to 
process a death, and the ability to remain 
optimistic and look beyond the loss, 
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Clinical implications 
In this thesis, I explored cognitive 
impairment, cognitive decline, cortisol 
levels and sleep quality of persons with 
prolonged grief disorder in a middle aged 
and older population. The findings invite 
some clinical reflections. 
The death of a loved one is one of the most 
stressful events in a person’s life, but most 
people learn to cope with the loss and 
reassume their lives. However, 9-20% of 
the persons will develop prolonged grief, 
and will remain severely distressed for 
years following the death (5,6).
I have found that prolonged grief disorder 
is cross-sectionally related to poor 
cognitive impairment and lower total 
brain volumes, and longitudinally to 
cognitive decline after 7 years of follow-
up. The results suggest that prolonged 
grief disorder may, in some persons, be 
part of a mild cognitive impairment. 
These findings could provide further 
evidence to promote the close monitoring 
of patients who are in a prolonged grieving 
process and test these persons for possible 
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cognitive deficits. Support techniques for 
prolonged grievers could include cognitive 
support and treatment or prevention of 
vascular risk factors, as these can slow the 
process of brain atrophy. They also must 
be monitored closely for development of 
Alzheimer’s Disease. Similarly, patients 
with known cognitive deﬁcits should be 
offered support for cognitive problems if 
confronted with the loss of a loved one to 
prevent prolonged grief disorder.
I also explored the association of 
prolonged grief disorder with the diurnal 
cortisol patterns in a large population-
based study. I found that they showed low 
levels of morning cortisol and low overall 
diurnal cortisol levels. The results suggest 
that prolonged grief disorder has classic 
characteristics of a chronic stress reaction. 
This finding suggests psychological 
and social support to persons who are 
in a prolonged grieving process may 
be helpful. It also suggests that group 
therapies focuses on relaxing therapies 
like mindfulness should be tested to 
diminish the stress associated with the 
are both thought to be effective means 
of coping with loss and other aversive 
events. Recently, these seemingly contrary 
dimensions have been integrated into a 
model of coping flexibility (82).
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loss, and reduce the likelihood of develop 
cognitive problems.
The thesis also explored the vascular 
depression hypothesis. I found that early 
vascular changes such as non-clinical 
white matter lesions, silent brain infarcts 
and cerebral microbleeds increase the risk 
of incident depression and the recurrence 
of depression. These findings indicate 
that is very important to strengthen 
education about vascular health and the 
prevention programs of vascular diseases 
in the programs combatting depressive 
disorders in later-life.
Future directions for research
Future studies should include younger 
people who lose a loved person. I think 
that it is important to evaluate cognitive 
impairment, general health, cortisol 
levels, and perform brain imaging in early 
ages. Elsewise reverse causality cannot be 
ruled out, only this design gives us the 
possibility to follow them for 10 or 20 
years to address the following issues: the 
extent to which prolonged grief disorder 
is predictive of cognitive problems, the 
extent to which prolonged grief disorder 
is predictive of long- term morbidity; and 
ultimately the development and study of 
therapies for its treatment. It would also 
be interesting to evaluate if prolonged 
grief disorder could be considered a 
marker of dementia.
Concluding remarks 
Prolonged grief disorder is a pathology not 
well-known, with an enormous impact on 
the social, psychological and biological 
area of a person. Having prolonged grief 
disorder changes the life of a person 
enormously, leaving him or her stuck 
in time, without the desire to continue 
living and without goals or project for the 
future. Working on this thesis and having 
the opportunity to treat patients with 
prolonged grief disorder, has allowed me 
to have a broad vision on this pathological 
condition. I see the need for more studies 
to be carried out in order to understand 
its characteristics and its evolution. More 
epidemiological studies are needed to 
pave the way for strategies for early 
detection and novel interventions to help 
these people have “full” lives.
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Summary
Experiencing the death of a significant 
person is an event that most people 
will encounter multiple times in their 
lives, and is often perceived as a severely 
stressing experience. Grief is the most 
usual reaction to such a loss and thus 
considered a normal and natural 
transition. About 9-20% of the persons 
cannot deal with the loss however, and 
will show symptoms of complicated and 
unresolved grief, termed prolonged grief 
disorder (PGD) (chapter 1). 
In chapter 2, I explored the cross-sectional 
association of PGD with cognitive 
performance, and tested whether there 
are differences in brain volumetric 
measures between persons with and 
without symptoms of complicated grief. 
I found an association between PGD and 
poor cognitive performance. Persons with 
PGD had lower scores on a Letter-Digit 
Substitution test and a Word Fluency 
Task. In addition, I found that persons 
with PGD were more likely to have a 
smaller total brain volume. 
In chapter 3, I aimed to compare the 
cognitive decline between persons with 
SUMMARY
normal grief or PGD, and a non-grieving 
reference population in a 7-year follow-
up study. Persons with PGD showed a 
stronger cognitive decline (decrease in 
global cognitive function, performance 
on a dementia screener, and learning and 
recalling words) over time than the non-
grieving persons.
Chapter 4 shows the association of PGD 
with sleep duration and sleep quality. In 
this study, PGD was associated cross-
sectionally with shorter sleep duration 
and lower sleep quality, but no association 
was found longitudinally. The high level of 
prevalent sleep disturbances was mainly 
explained by depressive symptoms.
In chapter 5, I examined the association 
of morning cortisol and summary cortisol 
measures with prevalent grief and recently 
occurring PGD (e.g., loss occurred in last 
two years). I found that persons with PGD 
had lower levels of morning cortisol and 
lower overall diurnal cortisol levels than 
those without grief.  In contrast, persons 
with normal grief showed similar cortisol 
secretion patterns as those without grief. 
Also, no association of grief or PGD with 
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cortisol secretion patterns was observed, 
if persons with longer periods since the 
loss were included. This suggests that 
even persons with severe grief may adapt 
to the loss and the resulting physiological 
changes normalize after some years.
In chapter 6, I tested the longitudinal 
association of non-clinical cerebral small 
vessel disease with depression in the 
general population. I found that older 
adults with so-called silent brain infarcts, 
infarcts that have not been clinically 
diagnosed, had an almost three-fold 
risk of recurrent depression episode 
during a mean follow-up of 3.6 years. 
This study suggests that the associations 
of silent brain infarcts and white matter 
lesions with depression is not due to 
dementia; and is independent of a history 
of depression, suggesting that vascular 
brain damage precedes the depressive 
disorder, rather than being a consequence 
of depression. 
In chapter 7, I explored cross-sectional 
the association of white matter lesions, 
lacunar infarcts and cerebral microbleeds 
with different severity degrees of 
depression. White matter lesions volumes 
and lacunar infarcts were associated with 
more depressive symptoms and major 
depressive disorder. Cerebral microbleeds, 
especially in deep or infratentorial 
brain regions, were related to depressive 
disorders in stroke-free participants. 
In chapter 8, I discuss the most important 
findings of the studies and summarize 
methodological issues and clinical 
implications.
157
Summary
Bijna iedereen krijgt te maken met het 
overlijden van een dierbare, waarschijnlijk 
zelfs meer dan eens. Voor de meesten 
van ons is dit een emotionele ervaring 
die gepaard gaat met rouw, verdriet en 
stress. Rouw is een gebruikelijke reactie 
op het verlies van een dierbare en een 
natuurlijk transitie proces. Ongeveer 9 
tot 20% ervaart echter problemen met 
de rouwverwerking, waarbij het verdriet 
complex en onverwerkt is. Dit wordt 
ook wel gecompliceerde rouw genoemd 
(hoofdstuk 1).
In hoofdstuk 2 onderzoek ik de cross-
sectionele associatie van gecompliceerde 
rouw met cognitief functioneren en 
ook of er verschillen in brein volume 
bestaan tussen mensen met en zonder 
symptomen van gecompliceerde rouw. 
Uit mijn onderzoek kwam een verband 
tussen gecompliceerde rouw en cognitief 
functioneren naar voren; mensen met 
gecompliceerde rouw behaalden lagere 
scores op een substitutie en woord 
vloeiendheid taak. Daarnaast vond ik dat 
in mensen met gecompliceerde rouw een 
kleiner brein volume hadden.
SAMENVATTING
In hoofdstuk 3 vergelijk ik de cognitieve 
achteruitgang tussen mensen met normale 
rouw, gecompliceerde rouw en zonder 
rouw. We volgden deze groep mensen 
voor 7 jaar en lieten zien dat mensen 
met gecompliceerde rouw een sterkere 
cognitieve achteruitgang dan mensen 
zonder rouw ervoeren over deze 7 jaar, 
dat wil zeggen een verminderd algeheel 
cognitief functioneren, verlaagde scores 
op een dementie screeningsinstrument en 
een verminderde prestatie bij het leren en 
ophalen van verbale informatie.
Hoofdstuk 4 demonstreert het verband 
tussen gecompliceerde rouw en slaap. In 
onze studie liet gecompliceerde rouw een 
cross-sectioneel verband met een kortere 
slaapduur en lagere slaap kwaliteit zien, 
maar dit verband werd niet longitudinaal 
gevonden. De veel gerapporteerde slaap 
problemen werden in plaats daarvan 
voornamelijk door symptomen van 
depressie veroorzaakt.
In hoofdstuk 5 heb ik het verband 
tussen cortisol, gemeten in de ochtend 
en gemiddeld over de dag, en rouw 
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onderzocht. Mensen met recente 
gecompliceerder rouw, dat wil zeggen met 
een verlies gedurende de voorgaande twee 
jaar, hadden een lager cortisol niveau in 
de ochtend en ook een lager gemiddeld 
cortisol niveau over de gehele dag in 
vergelijking met mensen die niet in rouw 
waren. Daarentegen waren de cortisol 
niveaus van mensen met ‘normale’ rouw 
en mensen met gecompliceerde rouw 
waarbij het verlies meer dan twee jaar 
geleden was vergelijkbaar met de cortisol 
niveaus van mensen die niet in rouw 
waren. Dit suggereert dat ook mensen 
met langdurige gecompliceerde rouw 
uiteindelijk adapteren aan hun verlies 
en dat de bijbehorende fysiologische 
veranderingen na meerdere jaren 
normaliseren.
In hoofdstuk 6 test ik de longitudinale 
associatie van aandoeningen in de kleine 
bloedvaten met depressieve episoden in de 
algemene bevolking. Ik vond dat ouderen 
met zogenaamde ‘stille’ herseninfarcten, 
dat wil zeggen herseninfarcten die niet 
klinisch gediagnosticeerd zijn, een bijna 
drie keer zo hoog risico hadden op een 
recidive depressieve episode over een 
gemiddelde periode van 3.6 jaar. Dit 
verhoogde risico in mensen met een ‘stil’ 
herseninfarct en witte stof laesies kon 
niet verklaard worden door dementie, 
en was onafhankelijk van de medische 
voorgeschiedenis met betrekking tot 
depressie. Dit lijkt er op te duiden dat 
vaatschade in de hersenen voorafgaat aan 
depressie, en niet een gevolg is van de 
depressie.
In hoofdstuk 7 onderzoek ik het cross-
sectionele verband van witte stof 
laesies, lacunaire infarcten en cerebrale 
microbloedingen met depressie. Een 
hoger volume witte stof laesies en meer 
lacunaire infarcten waren geassocieerd 
met meer depressieve symptomen en 
meer depressieve stoornis diagnoses. Het 
hebben van cerebrale microbloedingen, 
in het bijzonder diep in het brein en in de 
infratentoriale regio’s van het brein, was 
eveneens gerelateerd aan meer depressieve 
stoornissen in deelnemers zonder een 
voorgeschiedenis van beroerte.
In hoofdstuk 8 bespreek ik als laatste de 
meest belangrijke bevindingen van mijn 
werk en vat ik methodologische kwesties 
en klinische implicaties samen.
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